{"id": "BioInfer.d630.s0_BioInfer.d630.s0.p0", "text": "The interaction of a mouse monoclonal antibody (4A6) and birch profilin, a structurally well conserved actin- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "text_with_entity_marker": "The interaction of a mouse monoclonal antibody ([E1]4A6[/E1]) and birch [E2]profilin[/E2], a structurally well conserved actin- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "4A6", "entity_1_idx": [[48, 51]], "entity_1_idx_in_text_with_entity_marker": [52, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[63, 71]], "entity_2_idx_in_text_with_entity_marker": [76, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d630.s0_BioInfer.d630.s0.p1", "text": "The interaction of a mouse monoclonal antibody (4A6) and birch profilin, a structurally well conserved actin- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "text_with_entity_marker": "The interaction of a mouse monoclonal antibody ([E1]4A6[/E1]) and birch profilin, a structurally well conserved [E2]actin[/E2]- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4A6", "entity_1_idx": [[48, 51]], "entity_1_idx_in_text_with_entity_marker": [52, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d630.s0_BioInfer.d630.s0.p2", "text": "The interaction of a mouse monoclonal antibody (4A6) and birch profilin, a structurally well conserved actin- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "text_with_entity_marker": "The interaction of a mouse monoclonal antibody (4A6) and birch [E1]profilin[/E1], a structurally well conserved [E2]actin[/E2]- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[63, 71]], "entity_1_idx_in_text_with_entity_marker": [67, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d667.s0_BioInfer.d667.s0.p0", "text": "The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "text_with_entity_marker": "The primary purpose of this study was to determine the relationship between myosin heavy chain ([E1]MHC[/E1]) and [E2]actin[/E2] contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d667.s0_BioInfer.d667.s0.p1", "text": "The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "text_with_entity_marker": "The primary purpose of this study was to determine the relationship between [E1]myosin heavy chain[/E1] (MHC) and [E2]actin[/E2] contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d667.s0_BioInfer.d667.s0.p2", "text": "The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "text_with_entity_marker": "The primary purpose of this study was to determine the relationship between [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s1_BioInfer.d267.s1.p2", "text": "NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.", "text_with_entity_marker": "NLS-less S.cerevisiae proteins include both [E1]RAD51[/E1] and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and [E2]HRR25[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HRR25", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s1_BioInfer.d267.s1.p3", "text": "NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.", "text_with_entity_marker": "NLS-less S.cerevisiae proteins include both RAD51 and [E1]RAD52[/E1] that function in the recombination and in the repair of double-strand breaks as well as the [E2]RAD23[/E2] and HRR25 molecules.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD23", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s1_BioInfer.d267.s1.p4", "text": "NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.", "text_with_entity_marker": "NLS-less S.cerevisiae proteins include both [E1]RAD51[/E1] and [E2]RAD52[/E2] that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s1_BioInfer.d267.s1.p5", "text": "NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.", "text_with_entity_marker": "NLS-less S.cerevisiae proteins include both [E1]RAD51[/E1] and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the [E2]RAD23[/E2] and HRR25 molecules.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD23", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p10", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of [E1]profilin[/E1] in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of [E2]actin[/E2] released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[143, 151]], "entity_1_idx_in_text_with_entity_marker": [147, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[264, 269]], "entity_2_idx_in_text_with_entity_marker": [277, 282], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p11", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of [E1]actin[/E1] released from profilin too small to account for the large shifts from unpolymerized to polymerized [E2]actin[/E2] associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[264, 269]], "entity_1_idx_in_text_with_entity_marker": [268, 273], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[369, 374]], "entity_2_idx_in_text_with_entity_marker": [382, 387], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p12", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of [E1]actin[/E1] released from [E2]profilin[/E2] too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[264, 269]], "entity_1_idx_in_text_with_entity_marker": [268, 273], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[284, 292]], "entity_2_idx_in_text_with_entity_marker": [297, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p13", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released [E1]actin[/E1] at the appropriate time to stimulate [E2]actin[/E2] assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p14", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate [E1]actin[/E1] assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized [E2]actin[/E2] content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[210, 215]], "entity_2_idx_in_text_with_entity_marker": [223, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p15", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate [E1]actin[/E1] assembly during exposure to chemoattractants, the concentration of [E2]profilin[/E2] in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[143, 151]], "entity_2_idx_in_text_with_entity_marker": [156, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p16", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate [E1]actin[/E1] assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized [E2]actin[/E2] associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[369, 374]], "entity_2_idx_in_text_with_entity_marker": [382, 387], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p17", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate [E1]actin[/E1] assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from [E2]profilin[/E2] too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[284, 292]], "entity_2_idx_in_text_with_entity_marker": [297, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p18", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released [E1]actin[/E1] at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized [E2]actin[/E2] content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[210, 215]], "entity_2_idx_in_text_with_entity_marker": [223, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p19", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released [E1]actin[/E1] at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of [E2]profilin[/E2] in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[143, 151]], "entity_2_idx_in_text_with_entity_marker": [156, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p0", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, [E1]basic calponin[/E1] and the smooth muscle myosin heavy-chain isoforms of SM1 and [E2]SM2[/E2]) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "basic calponin", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM2", "entity_2_idx": [[178, 181]], "entity_2_idx_in_text_with_entity_marker": [191, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p1", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins ([E1]desmin[/E1], alpha-smooth muscle actin, [E2]basic calponin[/E2] and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[67, 73]], "entity_1_idx_in_text_with_entity_marker": [71, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "basic calponin", "entity_2_idx": [[102, 116]], "entity_2_idx_in_text_with_entity_marker": [115, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p2", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, [E1]basic calponin[/E1] and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-[E2]polymerase[/E2] chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "basic calponin", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "polymerase", "entity_2_idx": [[358, 368]], "entity_2_idx_in_text_with_entity_marker": [371, 381], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p3", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, [E1]basic calponin[/E1] and the [E2]smooth muscle myosin heavy-chain[/E2] isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "basic calponin", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy-chain", "entity_2_idx": [[125, 157]], "entity_2_idx_in_text_with_entity_marker": [138, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p4", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, [E1]alpha-smooth muscle actin[/E1], [E2]basic calponin[/E2] and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[75, 100]], "entity_1_idx_in_text_with_entity_marker": [79, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "basic calponin", "entity_2_idx": [[102, 116]], "entity_2_idx_in_text_with_entity_marker": [115, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p5", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, [E1]basic calponin[/E1] and the smooth muscle myosin heavy-chain isoforms of [E2]SM1[/E2] and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "basic calponin", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM1", "entity_2_idx": [[170, 173]], "entity_2_idx_in_text_with_entity_marker": [183, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p6", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins ([E1]desmin[/E1], alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and [E2]SM2[/E2]) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[67, 73]], "entity_1_idx_in_text_with_entity_marker": [71, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM2", "entity_2_idx": [[178, 181]], "entity_2_idx_in_text_with_entity_marker": [191, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p7", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and [E1]SM2[/E1]) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-[E2]polymerase[/E2] chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM2", "entity_1_idx": [[178, 181]], "entity_1_idx_in_text_with_entity_marker": [182, 185], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "polymerase", "entity_2_idx": [[358, 368]], "entity_2_idx_in_text_with_entity_marker": [371, 381], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p8", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the [E1]smooth muscle myosin heavy-chain[/E1] isoforms of SM1 and [E2]SM2[/E2]) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "smooth muscle myosin heavy-chain", "entity_1_idx": [[125, 157]], "entity_1_idx_in_text_with_entity_marker": [129, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SM2", "entity_2_idx": [[178, 181]], "entity_2_idx_in_text_with_entity_marker": [191, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p9", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, [E1]alpha-smooth muscle actin[/E1], basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and [E2]SM2[/E2]) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[75, 100]], "entity_1_idx_in_text_with_entity_marker": [79, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM2", "entity_2_idx": [[178, 181]], "entity_2_idx_in_text_with_entity_marker": [191, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p10", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of [E1]SM1[/E1] and [E2]SM2[/E2]) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM1", "entity_1_idx": [[170, 173]], "entity_1_idx_in_text_with_entity_marker": [174, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SM2", "entity_2_idx": [[178, 181]], "entity_2_idx_in_text_with_entity_marker": [191, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p11", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins ([E1]desmin[/E1], alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-[E2]polymerase[/E2] chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[67, 73]], "entity_1_idx_in_text_with_entity_marker": [71, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "polymerase", "entity_2_idx": [[358, 368]], "entity_2_idx_in_text_with_entity_marker": [371, 381], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p12", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins ([E1]desmin[/E1], alpha-smooth muscle actin, basic calponin and the [E2]smooth muscle myosin heavy-chain[/E2] isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[67, 73]], "entity_1_idx_in_text_with_entity_marker": [71, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy-chain", "entity_2_idx": [[125, 157]], "entity_2_idx_in_text_with_entity_marker": [138, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p13", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins ([E1]desmin[/E1], [E2]alpha-smooth muscle actin[/E2], basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[67, 73]], "entity_1_idx_in_text_with_entity_marker": [71, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[75, 100]], "entity_2_idx_in_text_with_entity_marker": [88, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p14", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins ([E1]desmin[/E1], alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of [E2]SM1[/E2] and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[67, 73]], "entity_1_idx_in_text_with_entity_marker": [71, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM1", "entity_2_idx": [[170, 173]], "entity_2_idx_in_text_with_entity_marker": [183, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p15", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the [E1]smooth muscle myosin heavy-chain[/E1] isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-[E2]polymerase[/E2] chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin heavy-chain", "entity_1_idx": [[125, 157]], "entity_1_idx_in_text_with_entity_marker": [129, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "polymerase", "entity_2_idx": [[358, 368]], "entity_2_idx_in_text_with_entity_marker": [371, 381], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p16", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, [E1]alpha-smooth muscle actin[/E1], basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-[E2]polymerase[/E2] chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[75, 100]], "entity_1_idx_in_text_with_entity_marker": [79, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "polymerase", "entity_2_idx": [[358, 368]], "entity_2_idx_in_text_with_entity_marker": [371, 381], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p17", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of [E1]SM1[/E1] and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-[E2]polymerase[/E2] chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM1", "entity_1_idx": [[170, 173]], "entity_1_idx_in_text_with_entity_marker": [174, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "polymerase", "entity_2_idx": [[358, 368]], "entity_2_idx_in_text_with_entity_marker": [371, 381], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p18", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, [E1]alpha-smooth muscle actin[/E1], basic calponin and the [E2]smooth muscle myosin heavy-chain[/E2] isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[75, 100]], "entity_1_idx_in_text_with_entity_marker": [79, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy-chain", "entity_2_idx": [[125, 157]], "entity_2_idx_in_text_with_entity_marker": [138, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p19", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the [E1]smooth muscle myosin heavy-chain[/E1] isoforms of [E2]SM1[/E2] and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "smooth muscle myosin heavy-chain", "entity_1_idx": [[125, 157]], "entity_1_idx_in_text_with_entity_marker": [129, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SM1", "entity_2_idx": [[170, 173]], "entity_2_idx_in_text_with_entity_marker": [183, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d378.s0_BioInfer.d378.s0.p20", "text": "In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "text_with_entity_marker": "In this study, the expressions of smooth muscle-specific proteins (desmin, [E1]alpha-smooth muscle actin[/E1], basic calponin and the smooth muscle myosin heavy-chain isoforms of [E2]SM1[/E2] and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[75, 100]], "entity_1_idx_in_text_with_entity_marker": [79, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM1", "entity_2_idx": [[170, 173]], "entity_2_idx_in_text_with_entity_marker": [183, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p60", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E2]AP-1[/E2] and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p61", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E2]p38[/E2] MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p38", "entity_2_idx": [[325, 328]], "entity_2_idx_in_text_with_entity_marker": [338, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p62", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E2]mitogen-activated protein kinase[/E2] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[198, 230]], "entity_2_idx_in_text_with_entity_marker": [211, 243], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p63", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E1]extracellular signal regulated protein kinase[/E1] and c-Jun N-terminal kinase, but not via p38 [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "extracellular signal regulated protein kinase", "entity_1_idx": [[238, 283]], "entity_1_idx_in_text_with_entity_marker": [242, 287], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p64", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E1]MAPK[/E1])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAPK", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p65", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E1]AP-1[/E1] and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AP-1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p66", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E1]p38[/E1] [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p38", "entity_1_idx": [[325, 328]], "entity_1_idx_in_text_with_entity_marker": [329, 332], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p67", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E1]mitogen-activated protein kinase[/E1] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[198, 230]], "entity_1_idx_in_text_with_entity_marker": [202, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p68", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E1]MAPK[/E1])/[E2]extracellular signal regulated protein kinase[/E2] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAPK", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "extracellular signal regulated protein kinase", "entity_2_idx": [[238, 283]], "entity_2_idx_in_text_with_entity_marker": [251, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p69", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E1]AP-1[/E1] and pathways via mitogen-activated protein kinase (MAPK)/[E2]extracellular signal regulated protein kinase[/E2] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AP-1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "extracellular signal regulated protein kinase", "entity_2_idx": [[238, 283]], "entity_2_idx_in_text_with_entity_marker": [251, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p0", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain ([E1]MHC[/E1]), and [E2]actin[/E2], but not desmin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[189, 192]], "entity_1_idx_in_text_with_entity_marker": [193, 196], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p1", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, [E1]myosin heavy chain[/E1] (MHC), and [E2]actin[/E2], but not desmin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[169, 187]], "entity_1_idx_in_text_with_entity_marker": [173, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p2", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and [E1]actin[/E1], but not [E2]desmin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[199, 204]], "entity_1_idx_in_text_with_entity_marker": [203, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[214, 220]], "entity_2_idx_in_text_with_entity_marker": [227, 233], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p3", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]), and actin, but not desmin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[169, 187]], "entity_1_idx_in_text_with_entity_marker": [173, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[189, 192]], "entity_2_idx_in_text_with_entity_marker": [202, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p4", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain ([E1]MHC[/E1]), and actin, but not [E2]desmin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[189, 192]], "entity_1_idx_in_text_with_entity_marker": [193, 196], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[214, 220]], "entity_2_idx_in_text_with_entity_marker": [227, 233], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p5", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, [E1]myosin heavy chain[/E1] (MHC), and actin, but not [E2]desmin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[169, 187]], "entity_1_idx_in_text_with_entity_marker": [173, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[214, 220]], "entity_2_idx_in_text_with_entity_marker": [227, 233], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p20", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p21", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, [E2]vimentin[/E2] CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p22", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p23", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p24", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p25", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [58, 59]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p26", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [58, 59]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p27", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p28", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] ([E2]CKs[/E2]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKs", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p29", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [58, 59]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p40", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p41", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E1]S-100[/E1] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "S-100", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p42", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins ([E1]CKs[/E1]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKs", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p43", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p44", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p45", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E1]EMA[/E1]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EMA", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p46", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p47", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E1]type IV collagen[/E1], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "type IV collagen", "entity_1_idx": [[147, 163]], "entity_1_idx_in_text_with_entity_marker": [151, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p48", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, [E1]vimentin[/E1] CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[132, 140]], "entity_1_idx_in_text_with_entity_marker": [136, 144], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p49", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E1]smooth muscle myosin heavy chain[/E1], calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[186, 218]], "entity_1_idx_in_text_with_entity_marker": [190, 222], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p80", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), [E2]epithelial membrane antigen[/E2] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "epithelial membrane antigen", "entity_2_idx": [[82, 109]], "entity_2_idx_in_text_with_entity_marker": [95, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p81", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, [E1]vimentin[/E1] CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[132, 140]], "entity_1_idx_in_text_with_entity_marker": [136, 144], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p82", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E1]type IV collagen[/E1], smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "type IV collagen", "entity_1_idx": [[147, 163]], "entity_1_idx_in_text_with_entity_marker": [151, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p83", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E1]type IV collagen[/E1], [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "type IV collagen", "entity_1_idx": [[147, 163]], "entity_1_idx_in_text_with_entity_marker": [151, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p84", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E1]CD34[/E1], [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p85", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p86", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p87", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E1]type IV collagen[/E1], smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "type IV collagen", "entity_1_idx": [[147, 163]], "entity_1_idx_in_text_with_entity_marker": [151, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p88", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins ([E1]CKs[/E1]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKs", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p89", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p0", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these [E1]collagens[/E1] on cell morphology and the distribution pattern of actin, [E2]vimentin[/E2], talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "collagens", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "vimentin", "entity_2_idx": [[91, 99]], "entity_2_idx_in_text_with_entity_marker": [104, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p1", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these [E1]collagens[/E1] on cell morphology and the distribution pattern of [E2]actin[/E2], vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "collagens", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p2", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these [E1]collagens[/E1] on cell morphology and the distribution pattern of actin, vimentin, talin, and [E2]vinculin[/E2] was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "collagens", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "vinculin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p3", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these [E1]collagens[/E1] on cell morphology and the distribution pattern of actin, vimentin, [E2]talin[/E2], and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "collagens", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p4", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these collagens on cell morphology and the distribution pattern of [E1]actin[/E1], [E2]vimentin[/E2], talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[91, 99]], "entity_2_idx_in_text_with_entity_marker": [104, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p5", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these collagens on cell morphology and the distribution pattern of actin, [E1]vimentin[/E1], talin, and [E2]vinculin[/E2] was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[91, 99]], "entity_1_idx_in_text_with_entity_marker": [95, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p6", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these collagens on cell morphology and the distribution pattern of actin, [E1]vimentin[/E1], [E2]talin[/E2], and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[91, 99]], "entity_1_idx_in_text_with_entity_marker": [95, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p7", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these collagens on cell morphology and the distribution pattern of [E1]actin[/E1], vimentin, talin, and [E2]vinculin[/E2] was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p8", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these collagens on cell morphology and the distribution pattern of [E1]actin[/E1], vimentin, [E2]talin[/E2], and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p9", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, [E1]talin[/E1], and [E2]vinculin[/E2] was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p10", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, [E2]F[/E2]: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[287, 288]], "entity_2_idx_in_text_with_entity_marker": [300, 301], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p11", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, [E2]F[/E2]: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[287, 288]], "entity_2_idx_in_text_with_entity_marker": [300, 301], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p12", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, [E2]F[/E2]: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[287, 288]], "entity_2_idx_in_text_with_entity_marker": [300, 301], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p13", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E1]N[/E1]: 1301-1700, P: 1751-2190, M: 3571-4057, [E2]F[/E2]: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[245, 246]], "entity_1_idx_in_text_with_entity_marker": [249, 250], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F", "entity_2_idx": [[287, 288]], "entity_2_idx_in_text_with_entity_marker": [300, 301], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p14", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E1]P[/E1]: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[259, 260]], "entity_1_idx_in_text_with_entity_marker": [263, 264], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p15", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E1]L[/E1]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[109, 110]], "entity_1_idx_in_text_with_entity_marker": [113, 114], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p16", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E1]P[/E1]: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[259, 260]], "entity_1_idx_in_text_with_entity_marker": [263, 264], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p17", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p18", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein ([E1]P[/E1]), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p19", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s0_BioInfer.d1.s0.p0", "text": "A binary complex of birch profilin and skeletal muscle actin could be isolated by gel chromatography.", "text_with_entity_marker": "A binary complex of birch [E1]profilin[/E1] and [E2]skeletal muscle actin[/E2] could be isolated by gel chromatography.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[39, 60]], "entity_2_idx_in_text_with_entity_marker": [52, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p0", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch [E1]profilin[/E1] increased the critical concentration required for muscle and [E2]brain actin[/E2] polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "brain actin", "entity_2_idx": [[76, 87]], "entity_2_idx_in_text_with_entity_marker": [89, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p1", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch profilin increased the critical concentration required for [E1]muscle[/E1] and [E2]brain actin[/E2] polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscle", "entity_1_idx": [[65, 71], [82, 87]], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "brain actin", "entity_2_idx": [[76, 87]], "entity_2_idx_in_text_with_entity_marker": [89, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p2", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch profilin increased the critical concentration required for muscle and [E1]brain actin[/E1] polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "brain actin", "entity_1_idx": [[76, 87]], "entity_1_idx_in_text_with_entity_marker": [80, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[242, 247]], "entity_2_idx_in_text_with_entity_marker": [255, 260], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p3", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch [E1]profilin[/E1] increased the critical concentration required for [E2]muscle[/E2] and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscle", "entity_2_idx": [[65, 71], [82, 87]], "entity_2_idx_in_text_with_entity_marker": [78, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p4", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch [E1]profilin[/E1] increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[242, 247]], "entity_2_idx_in_text_with_entity_marker": [255, 260], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p5", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch profilin increased the critical concentration required for [E1]muscle[/E1] and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscle", "entity_1_idx": [[65, 71], [82, 87]], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[242, 247]], "entity_2_idx_in_text_with_entity_marker": [255, 260], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s2_BioInfer.d1.s2.p0", "text": "Interaction of plant profilin with mammalian actin.", "text_with_entity_marker": "Interaction of plant [E1]profilin[/E1] with mammalian [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s3_BioInfer.d1.s3.p0", "text": "In viscometric assays, the birch protein was seen to modulate actin filament formation analogous to animal profilin.", "text_with_entity_marker": "In viscometric assays, the birch protein was seen to modulate [E1]actin[/E1] filament formation analogous to animal [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s4_BioInfer.d1.s4.p0", "text": "These data indicate that the actin-binding domains in plant and animal profilins are functionally highly conserved, although the overall sequence similarity is less than 25%.", "text_with_entity_marker": "These data indicate that the [E1]actin[/E1]-binding domains in plant and animal [E2]profilins[/E2] are functionally highly conserved, although the overall sequence similarity is less than 25%.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[71, 80]], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p40", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I ([E1]TnI[/E1]) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TnI", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p41", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p42", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p43", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p44", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), [E1]desmin[/E1] and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[175, 181]], "entity_1_idx_in_text_with_entity_marker": [179, 185], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p45", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p46", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p47", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p48", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I ([E1]TnI[/E1]) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TnI", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p49", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), [E2]troponin I[/E2] (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "troponin I", "entity_2_idx": [[128, 138]], "entity_2_idx_in_text_with_entity_marker": [141, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p70", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p71", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p72", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E1]fusion protein[/E1] ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[286, 300]], "entity_1_idx_in_text_with_entity_marker": [290, 304], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p73", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E1]F0[/E1]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[302, 304]], "entity_1_idx_in_text_with_entity_marker": [306, 308], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p74", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E1]F0[/E1]) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[302, 304]], "entity_1_idx_in_text_with_entity_marker": [306, 308], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p75", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E1]fusion protein[/E1] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[286, 300]], "entity_1_idx_in_text_with_entity_marker": [290, 304], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p76", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E1]fusion protein[/E1] (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[286, 300]], "entity_1_idx_in_text_with_entity_marker": [290, 304], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p77", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E1]hemagglutinin-neuraminidase protein[/E1] ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hemagglutinin-neuraminidase protein", "entity_1_idx": [[342, 377]], "entity_1_idx_in_text_with_entity_marker": [346, 381], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p9", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, ADF and [E1]cofilin[/E1] colocalized in the same nuclear [E2]actin[/E2] rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[23, 30]], "entity_1_idx_in_text_with_entity_marker": [27, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p30", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone [E1]H3[/E1]: with the purified [E2]acetylase[/E2], histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[120, 122]], "entity_1_idx_in_text_with_entity_marker": [124, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylase", "entity_2_idx": [[142, 151]], "entity_2_idx_in_text_with_entity_marker": [155, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p31", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone [E1]H3[/E1]: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous [E2]acetylase(s)[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[120, 122]], "entity_1_idx_in_text_with_entity_marker": [124, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylase(s)", "entity_2_idx": [[301, 313]], "entity_2_idx_in_text_with_entity_marker": [314, 326], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p32", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of [E1]histone[/E1] [E2]H3[/E2]: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[120, 122]], "entity_2_idx_in_text_with_entity_marker": [133, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p33", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone [E1]H3[/E1]: with the purified acetylase, histone [E2]H4[/E2] in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[120, 122]], "entity_1_idx_in_text_with_entity_marker": [124, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p34", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone [E1]H3[/E1]: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was [E2]histone[/E2] H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[120, 122]], "entity_1_idx_in_text_with_entity_marker": [124, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[228, 235]], "entity_2_idx_in_text_with_entity_marker": [241, 248], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p35", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified [E1]acetylase[/E1], histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous [E2]acetylase(s)[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acetylase", "entity_1_idx": [[142, 151]], "entity_1_idx_in_text_with_entity_marker": [146, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylase(s)", "entity_2_idx": [[301, 313]], "entity_2_idx_in_text_with_entity_marker": [314, 326], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p36", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of [E1]histone[/E1] H3: with the purified [E2]acetylase[/E2], histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "acetylase", "entity_2_idx": [[142, 151]], "entity_2_idx_in_text_with_entity_marker": [155, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p37", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified [E1]acetylase[/E1], histone [E2]H4[/E2] in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "acetylase", "entity_1_idx": [[142, 151]], "entity_1_idx_in_text_with_entity_marker": [146, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p38", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified [E1]acetylase[/E1], histone H4 in nucleosomes was acetylated to a much greater extent than was [E2]histone[/E2] H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acetylase", "entity_1_idx": [[142, 151]], "entity_1_idx_in_text_with_entity_marker": [146, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[228, 235]], "entity_2_idx_in_text_with_entity_marker": [241, 248], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p39", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of [E1]histone[/E1] H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous [E2]acetylase(s)[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "acetylase(s)", "entity_2_idx": [[301, 313]], "entity_2_idx_in_text_with_entity_marker": [314, 326], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p40", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone [E1]H4[/E1] in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous [E2]acetylase(s)[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H4", "entity_1_idx": [[161, 163]], "entity_1_idx_in_text_with_entity_marker": [165, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acetylase(s)", "entity_2_idx": [[301, 313]], "entity_2_idx_in_text_with_entity_marker": [314, 326], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p41", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was [E1]histone[/E1] H3, whereas the reverse preference was found with the endogenous [E2]acetylase(s)[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[228, 235]], "entity_1_idx_in_text_with_entity_marker": [232, 239], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "acetylase(s)", "entity_2_idx": [[301, 313]], "entity_2_idx_in_text_with_entity_marker": [314, 326], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p42", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of [E1]histone[/E1] H3: with the purified acetylase, histone [E2]H4[/E2] in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p43", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of [E1]histone[/E1] H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was [E2]histone[/E2] H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[228, 235]], "entity_2_idx_in_text_with_entity_marker": [241, 248], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p44", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone [E1]H4[/E1] in nucleosomes was acetylated to a much greater extent than was [E2]histone[/E2] H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[161, 163]], "entity_1_idx_in_text_with_entity_marker": [165, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[228, 235]], "entity_2_idx_in_text_with_entity_marker": [241, 248], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p0", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "END5 encodes a proline-rich protein ([E1]End5p[/E1] or [E2]verprolin[/E2]) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "End5p", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[46, 55]], "entity_2_idx_in_text_with_entity_marker": [59, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p1", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "[E1]END5[/E1] encodes a proline-rich protein ([E2]End5p[/E2] or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "END5", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "End5p", "entity_2_idx": [[37, 42]], "entity_2_idx_in_text_with_entity_marker": [50, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p2", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "END5 encodes a proline-rich protein ([E1]End5p[/E1] or verprolin) required for a polarised cortical [E2]actin[/E2] cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "End5p", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p3", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "[E1]END5[/E1] encodes a proline-rich protein (End5p or [E2]verprolin[/E2]) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "END5", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "verprolin", "entity_2_idx": [[46, 55]], "entity_2_idx_in_text_with_entity_marker": [59, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p4", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "END5 encodes a proline-rich protein (End5p or [E1]verprolin[/E1]) required for a polarised cortical [E2]actin[/E2] cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "verprolin", "entity_1_idx": [[46, 55]], "entity_1_idx_in_text_with_entity_marker": [50, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d190.s0_BioInfer.d190.s0.p5", "text": "END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].", "text_with_entity_marker": "[E1]END5[/E1] encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical [E2]actin[/E2] cytoskeleton and endocytosis [2,3].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "END5", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p0", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "[E1]alpha-Sm actin[/E1] inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, [E2]talin[/E2], and beta1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-Sm actin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p1", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, [E1]talin[/E1], and [E2]beta1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[147, 152]], "entity_1_idx_in_text_with_entity_marker": [151, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1-integrin", "entity_2_idx": [[158, 172]], "entity_2_idx_in_text_with_entity_marker": [171, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p2", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against [E1]vinculin[/E1], [E2]talin[/E2], and beta1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p3", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "[E1]alpha-Sm actin[/E1] inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and [E2]beta1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-Sm actin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1-integrin", "entity_2_idx": [[158, 172]], "entity_2_idx_in_text_with_entity_marker": [171, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p4", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "[E1]alpha-Sm actin[/E1] inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against [E2]vinculin[/E2], talin, and beta1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-Sm actin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p5", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against [E1]vinculin[/E1], talin, and [E2]beta1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1-integrin", "entity_2_idx": [[158, 172]], "entity_2_idx_in_text_with_entity_marker": [171, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d304.s0_BioInfer.d304.s0.p0", "text": "Impact of profilin on actin-bound nucleotide exchange and actin polymerization dynamics.", "text_with_entity_marker": "Impact of [E1]profilin[/E1] on [E2]actin[/E2]-bound nucleotide exchange and actin polymerization dynamics.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[10, 18]], "entity_1_idx_in_text_with_entity_marker": [14, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[22, 27]], "entity_2_idx_in_text_with_entity_marker": [35, 40], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d304.s0_BioInfer.d304.s0.p1", "text": "Impact of profilin on actin-bound nucleotide exchange and actin polymerization dynamics.", "text_with_entity_marker": "Impact of [E1]profilin[/E1] on actin-bound nucleotide exchange and [E2]actin[/E2] polymerization dynamics.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[10, 18]], "entity_1_idx_in_text_with_entity_marker": [14, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d304.s0_BioInfer.d304.s0.p2", "text": "Impact of profilin on actin-bound nucleotide exchange and actin polymerization dynamics.", "text_with_entity_marker": "Impact of profilin on [E1]actin[/E1]-bound nucleotide exchange and [E2]actin[/E2] polymerization dynamics.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p130", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E1]H2A.2[/E1], histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[250, 255]], "entity_1_idx_in_text_with_entity_marker": [254, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p131", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p132", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E1]histone[/E1] H2A.Z, histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[272, 279]], "entity_1_idx_in_text_with_entity_marker": [276, 283], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p133", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E1]histone[/E1] H2A.Z, histone [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[272, 279]], "entity_1_idx_in_text_with_entity_marker": [276, 283], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p134", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E1]histone[/E1] H2A.Z, histone H2B, three histone H3 variants and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[272, 279]], "entity_1_idx_in_text_with_entity_marker": [276, 283], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p135", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E1]histone[/E1] H2A.2, histone H2A.X, [E2]histone[/E2] H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[242, 249]], "entity_1_idx_in_text_with_entity_marker": [246, 253], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[272, 279]], "entity_2_idx_in_text_with_entity_marker": [285, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p136", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E2]histone[/E2] H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[272, 279]], "entity_2_idx_in_text_with_entity_marker": [285, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p137", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E2]histone[/E2] H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[272, 279]], "entity_2_idx_in_text_with_entity_marker": [285, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p138", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E2]histone[/E2] H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[272, 279]], "entity_2_idx_in_text_with_entity_marker": [285, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p139", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E2]histone[/E2] H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "histone", "entity_2_idx": [[272, 279]], "entity_2_idx_in_text_with_entity_marker": [285, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p0", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of [E1]E-cadherin[/E1], N-cadherin, [E2]alpha-catenin[/E2], or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[126, 139]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p1", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, [E1]alpha-catenin[/E1], or [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[126, 139]], "entity_1_idx_in_text_with_entity_marker": [130, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p2", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "[E1]P-cadherin[/E1] expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, [E2]alpha-catenin[/E2], or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P-cadherin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[126, 139]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p3", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, [E1]N-cadherin[/E1], [E2]alpha-catenin[/E2], or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[114, 124]], "entity_1_idx_in_text_with_entity_marker": [118, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[126, 139]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p4", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of [E1]E-cadherin[/E1], N-cadherin, alpha-catenin, or [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p5", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "[E1]P-cadherin[/E1] expression is a better indicator of clinical outcome than alterations in the expression of [E2]E-cadherin[/E2], N-cadherin, alpha-catenin, or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P-cadherin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[102, 112]], "entity_2_idx_in_text_with_entity_marker": [115, 125], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p6", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of [E1]E-cadherin[/E1], [E2]N-cadherin[/E2], alpha-catenin, or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[114, 124]], "entity_2_idx_in_text_with_entity_marker": [127, 137], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p7", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "[E1]P-cadherin[/E1] expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P-cadherin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p8", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, [E1]N-cadherin[/E1], alpha-catenin, or [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[114, 124]], "entity_1_idx_in_text_with_entity_marker": [118, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p9", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "[E1]P-cadherin[/E1] expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, [E2]N-cadherin[/E2], alpha-catenin, or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P-cadherin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[114, 124]], "entity_2_idx_in_text_with_entity_marker": [127, 137], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p0", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for [E1]pan-cadherin[/E1], E-cadherin, [E2]alpha-catenin[/E2], beta-catenin, and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pan-cadherin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p1", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]p120[/E2] was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p2", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[35, 45]], "entity_1_idx_in_text_with_entity_marker": [39, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p3", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[62, 74]], "entity_2_idx_in_text_with_entity_marker": [75, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p4", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for [E1]pan-cadherin[/E1], E-cadherin, alpha-catenin, beta-catenin, and [E2]p120[/E2] was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pan-cadherin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p5", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for [E1]pan-cadherin[/E1], [E2]E-cadherin[/E2], alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pan-cadherin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[35, 45]], "entity_2_idx_in_text_with_entity_marker": [48, 58], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p6", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for [E1]pan-cadherin[/E1], E-cadherin, alpha-catenin, [E2]beta-catenin[/E2], and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pan-cadherin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[62, 74]], "entity_2_idx_in_text_with_entity_marker": [75, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p7", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]p120[/E2] was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[35, 45]], "entity_1_idx_in_text_with_entity_marker": [39, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p8", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]p120[/E2] was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[62, 74]], "entity_1_idx_in_text_with_entity_marker": [66, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d302.s0_BioInfer.d302.s0.p9", "text": "Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.", "text_with_entity_marker": "Immunoreactivity for pan-cadherin, [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and p120 was observed in all 15 specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[35, 45]], "entity_1_idx_in_text_with_entity_marker": [39, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[62, 74]], "entity_2_idx_in_text_with_entity_marker": [75, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p80", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p81", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, [E2]MEC1[/E2], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[51, 55]], "entity_2_idx_in_text_with_entity_marker": [64, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p82", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 [E2]MEC3[/E2], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p83", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p84", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p85", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 [E2]MEC3[/E2], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p86", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p87", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p88", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p89", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p30", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-[E1]G[/E1]-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E2]phosphoprotein[/E2] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G", "entity_1_idx": [[46, 47]], "entity_1_idx_in_text_with_entity_marker": [50, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphoprotein", "entity_2_idx": [[157, 171]], "entity_2_idx_in_text_with_entity_marker": [170, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p31", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-[E1]G[/E1]-L-5', where N is the nucleocapsid protein gene; [E2]4a[/E2] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G", "entity_1_idx": [[46, 47]], "entity_1_idx_in_text_with_entity_marker": [50, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4a", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p32", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-[E1]G[/E1]-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E2]matrix protein[/E2] gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G", "entity_1_idx": [[46, 47]], "entity_1_idx_in_text_with_entity_marker": [50, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "matrix protein", "entity_2_idx": [[250, 264]], "entity_2_idx_in_text_with_entity_marker": [263, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p33", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-[E2]L[/E2]-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[48, 49]], "entity_2_idx_in_text_with_entity_marker": [61, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p34", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-[E2]L[/E2]-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[48, 49]], "entity_2_idx_in_text_with_entity_marker": [61, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p35", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-[E2]L[/E2]-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[48, 49]], "entity_2_idx_in_text_with_entity_marker": [61, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p36", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-[E2]L[/E2]-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[48, 49]], "entity_2_idx_in_text_with_entity_marker": [61, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p37", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-[E1]L[/E1]-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[48, 49]], "entity_1_idx_in_text_with_entity_marker": [52, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p38", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-[E1]L[/E1]-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[48, 49]], "entity_1_idx_in_text_with_entity_marker": [52, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p39", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-[E1]L[/E1]-5', where [E2]N[/E2] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[48, 49]], "entity_1_idx_in_text_with_entity_marker": [52, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N", "entity_2_idx": [[60, 61]], "entity_2_idx_in_text_with_entity_marker": [73, 74], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p140", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E1]phosphoprotein[/E1] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[157, 171]], "entity_1_idx_in_text_with_entity_marker": [161, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p141", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; [E1]4a[/E1] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p142", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E1]matrix protein[/E1] gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix protein", "entity_1_idx": [[250, 264]], "entity_1_idx_in_text_with_entity_marker": [254, 268], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p143", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the [E1]nucleocapsid protein[/E1] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p144", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E1]phosphoprotein[/E1] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[157, 171]], "entity_1_idx_in_text_with_entity_marker": [161, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p145", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; [E1]4a[/E1] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p146", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E1]matrix protein[/E1] gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix protein", "entity_1_idx": [[250, 264]], "entity_1_idx_in_text_with_entity_marker": [254, 268], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p147", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the [E1]nucleocapsid protein[/E1] gene; 4a and 4b are two genes, one of which codes for the proposed [E2]phosphoprotein[/E2] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[157, 171]], "entity_2_idx_in_text_with_entity_marker": [170, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p148", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the [E1]nucleocapsid protein[/E1] gene; [E2]4a[/E2] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "4a", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p149", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the [E1]nucleocapsid protein[/E1] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E2]matrix protein[/E2] gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix protein", "entity_2_idx": [[250, 264]], "entity_2_idx_in_text_with_entity_marker": [263, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p10", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of [E1]Ras[/E1] alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor ([E2]CKI[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKI", "entity_2_idx": [[276, 279]], "entity_2_idx_in_text_with_entity_marker": [289, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p11", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the [E1]p27[/E1] cyclin-dependent kinase inhibitor ([E2]CKI[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[237, 240]], "entity_1_idx_in_text_with_entity_marker": [241, 244], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKI", "entity_2_idx": [[276, 279]], "entity_2_idx_in_text_with_entity_marker": [289, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p12", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of [E1]cyclin E-dependent kinase[/E1] activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor ([E2]CKI[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E-dependent kinase", "entity_1_idx": [[140, 165]], "entity_1_idx_in_text_with_entity_marker": [144, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKI", "entity_2_idx": [[276, 279]], "entity_2_idx_in_text_with_entity_marker": [289, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p13", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of [E1]Ras[/E1] with [E2]Myc[/E2] allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[102, 105]], "entity_1_idx_in_text_with_entity_marker": [106, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Myc", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p14", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 [E1]CDK[/E1] activity or S phase, coexpression of Ras with [E2]Myc[/E2] allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Myc", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p15", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of [E1]Ras[/E1] alone will not induce G1 CDK activity or S phase, coexpression of Ras with [E2]Myc[/E2] allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Myc", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p16", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with [E1]Myc[/E1] allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the [E2]p27[/E2] cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myc", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[237, 240]], "entity_2_idx_in_text_with_entity_marker": [250, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p17", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with [E1]Myc[/E1] allows the generation of [E2]cyclin E-dependent kinase[/E2] activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Myc", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E-dependent kinase", "entity_2_idx": [[140, 165]], "entity_2_idx_in_text_with_entity_marker": [153, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p18", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 [E1]CDK[/E1] activity or S phase, coexpression of [E2]Ras[/E2] with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[102, 105]], "entity_2_idx_in_text_with_entity_marker": [115, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p19", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of [E1]Ras[/E1] alone will not induce G1 CDK activity or S phase, coexpression of [E2]Ras[/E2] with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[102, 105]], "entity_2_idx_in_text_with_entity_marker": [115, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p20", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the [E1]Rho GTPase[/E1] [E2]CDC42Hs[/E2] as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Rho GTPase", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDC42Hs", "entity_2_idx": [[49, 56]], "entity_2_idx_in_text_with_entity_marker": [62, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p21", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by [E2]CDC42Hs[/E2]-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p22", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p23", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like [E2]actin[/E2]-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p24", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific [E2]actin[/E2] structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p25", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the [E2]Rho GTPase[/E2] CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho GTPase", "entity_2_idx": [[38, 48]], "entity_2_idx_in_text_with_entity_marker": [51, 61], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p26", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by [E1]CDC42Hs[/E1]-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CDC42Hs", "entity_1_idx": [[162, 169]], "entity_1_idx_in_text_with_entity_marker": [166, 173], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p27", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like [E1]actin[/E1]-regulatory domains, but no specific actin structure regulated by [E2]CDC42Hs[/E2]-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p28", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific [E1]actin[/E1] structure regulated by [E2]CDC42Hs[/E2]-WASp has been identified.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p29", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the [E1]Rho GTPase[/E1] CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by [E2]CDC42Hs[/E2]-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho GTPase", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDC42Hs", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p0", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, [E1]MSH6[/E1], MLH1, and PMS2, but not [E2]MSH3[/E2], are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p1", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, MSH6, [E1]MLH1[/E1], and PMS2, but not [E2]MSH3[/E2], are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p2", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, [E1]MSH2[/E1], MSH6, MLH1, and PMS2, but not [E2]MSH3[/E2], are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p3", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and [E1]PMS2[/E1], but not [E2]MSH3[/E2], are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PMS2", "entity_1_idx": [[79, 83]], "entity_1_idx_in_text_with_entity_marker": [83, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p4", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, [E1]MSH6[/E1], [E2]MLH1[/E2], and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p5", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, [E1]MSH2[/E1], [E2]MSH6[/E2], MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[63, 67]], "entity_2_idx_in_text_with_entity_marker": [76, 80], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p6", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, [E1]MSH6[/E1], MLH1, and [E2]PMS2[/E2], but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS2", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p7", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, [E1]MSH2[/E1], MSH6, [E2]MLH1[/E2], and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p8", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, MSH6, [E1]MLH1[/E1], and [E2]PMS2[/E2], but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS2", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p9", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, [E1]MSH2[/E1], MSH6, MLH1, and [E2]PMS2[/E2], but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS2", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d336.s0_BioInfer.d336.s0.p0", "text": "In growth cones, myosin heavy chain B was most concentrated in the margin bordering the thickened, organelle-rich central region and the thin, actin-rich peripheral region.", "text_with_entity_marker": "In growth cones, [E1]myosin heavy chain B[/E1] was most concentrated in the margin bordering the thickened, organelle-rich central region and the thin, [E2]actin[/E2]-rich peripheral region.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain B", "entity_1_idx": [[17, 37]], "entity_1_idx_in_text_with_entity_marker": [21, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d336.s1_BioInfer.d336.s1.p0", "text": "Myosin heavy chain A staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of myosin heavy chain B.", "text_with_entity_marker": "[E1]Myosin heavy chain A[/E1] staining was dimmer and its colocalization with filamentous [E2]actin[/E2] bundles in growth cones was less striking than that of myosin heavy chain B.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Myosin heavy chain A", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d336.s1_BioInfer.d336.s1.p1", "text": "Myosin heavy chain A staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of myosin heavy chain B.", "text_with_entity_marker": "Myosin heavy chain A staining was dimmer and its colocalization with filamentous [E1]actin[/E1] bundles in growth cones was less striking than that of [E2]myosin heavy chain B[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain B", "entity_2_idx": [[142, 162]], "entity_2_idx_in_text_with_entity_marker": [155, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d336.s1_BioInfer.d336.s1.p2", "text": "Myosin heavy chain A staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of myosin heavy chain B.", "text_with_entity_marker": "[E1]Myosin heavy chain A[/E1] staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of [E2]myosin heavy chain B[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myosin heavy chain A", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain B", "entity_2_idx": [[142, 162]], "entity_2_idx_in_text_with_entity_marker": [155, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s0_BioInfer.d27.s0.p0", "text": "ADP-ribosylation of actin at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "ADP-ribosylation of [E1]actin[/E1] at Arg 177 by Clostridium perfringens [E2]iota toxin[/E2] increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "iota toxin", "entity_2_idx": [[64, 74]], "entity_2_idx_in_text_with_entity_marker": [77, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s0_BioInfer.d27.s0.p1", "text": "ADP-ribosylation of actin at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "ADP-ribosylation of [E1]actin[/E1] at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the [E2]profilin[/E2]-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s0_BioInfer.d27.s0.p2", "text": "ADP-ribosylation of actin at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "ADP-ribosylation of actin at Arg 177 by Clostridium perfringens [E1]iota toxin[/E1] increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the [E2]profilin[/E2]-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "iota toxin", "entity_1_idx": [[64, 74]], "entity_1_idx_in_text_with_entity_marker": [68, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s1_BioInfer.d27.s1.p0", "text": "In contrast, ADP-ribosylation of actin at Arg95/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "In contrast, ADP-ribosylation of actin at Arg95/Arg372 induced by turkey [E1]erythrocyte transferase[/E1] decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the [E2]profilin[/E2]-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "erythrocyte transferase", "entity_1_idx": [[73, 96]], "entity_1_idx_in_text_with_entity_marker": [77, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[177, 185]], "entity_2_idx_in_text_with_entity_marker": [190, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s1_BioInfer.d27.s1.p1", "text": "In contrast, ADP-ribosylation of actin at Arg95/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "In contrast, ADP-ribosylation of [E1]actin[/E1] at Arg95/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the [E2]profilin[/E2]-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[177, 185]], "entity_2_idx_in_text_with_entity_marker": [190, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s1_BioInfer.d27.s1.p2", "text": "In contrast, ADP-ribosylation of actin at Arg95/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "In contrast, ADP-ribosylation of [E1]actin[/E1] at Arg95/Arg372 induced by turkey [E2]erythrocyte transferase[/E2] decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "erythrocyte transferase", "entity_2_idx": [[73, 96]], "entity_2_idx_in_text_with_entity_marker": [86, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p0", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, [E1]UL29[/E1], [E2]UL30[/E2], UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL29", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL30", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p1", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, [E1]UL8[/E1], UL29, [E2]UL30[/E2], UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL30", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p2", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 [E1]UL5[/E1], UL8, UL29, [E2]UL30[/E2], UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL30", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p3", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, [E1]UL30[/E1], UL42, and UL52 gene products along with the AAV [E2]Rep68[/E2] protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL30", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rep68", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p4", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, [E1]UL30[/E1], UL42, and [E2]UL52[/E2] gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL30", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p5", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, [E1]UL30[/E1], [E2]UL42[/E2], and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL30", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p6", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, [E1]UL8[/E1], [E2]UL29[/E2], UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL29", "entity_2_idx": [[33, 37]], "entity_2_idx_in_text_with_entity_marker": [46, 50], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p7", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 [E1]UL5[/E1], UL8, [E2]UL29[/E2], UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL29", "entity_2_idx": [[33, 37]], "entity_2_idx_in_text_with_entity_marker": [46, 50], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p8", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, [E1]UL29[/E1], UL30, UL42, and UL52 gene products along with the AAV [E2]Rep68[/E2] protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL29", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rep68", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p9", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, [E1]UL29[/E1], UL30, UL42, and [E2]UL52[/E2] gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL29", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p10", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, [E1]UL29[/E1], UL30, [E2]UL42[/E2], and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL29", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p11", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 [E1]UL5[/E1], [E2]UL8[/E2], UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[28, 31]], "entity_2_idx_in_text_with_entity_marker": [41, 44], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p12", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, [E1]UL8[/E1], UL29, UL30, UL42, and UL52 gene products along with the AAV [E2]Rep68[/E2] protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rep68", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p13", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, [E1]UL8[/E1], UL29, UL30, UL42, and [E2]UL52[/E2] gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p14", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, [E1]UL8[/E1], UL29, UL30, [E2]UL42[/E2], and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p15", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 [E1]UL5[/E1], UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV [E2]Rep68[/E2] protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rep68", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p16", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 [E1]UL5[/E1], UL8, UL29, UL30, UL42, and [E2]UL52[/E2] gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p17", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 [E1]UL5[/E1], UL8, UL29, UL30, [E2]UL42[/E2], and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p18", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and [E1]UL52[/E1] gene products along with the AAV [E2]Rep68[/E2] protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rep68", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p19", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, UL30, [E1]UL42[/E1], and UL52 gene products along with the AAV [E2]Rep68[/E2] protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL42", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rep68", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p20", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, UL30, [E1]UL42[/E1], and [E2]UL52[/E2] gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL42", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p0", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "[E1]p21[/E1] (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen ([E2]PCNA[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p1", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "[E1]p21[/E1] (p21WAF1/[E2]Cip1[/E2]), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cip1", "entity_2_idx": [[13, 17]], "entity_2_idx_in_text_with_entity_marker": [26, 30], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p2", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "[E1]p21[/E1] ([E2]p21WAF1[/E2]/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21WAF1", "entity_2_idx": [[5, 12]], "entity_2_idx_in_text_with_entity_marker": [18, 25], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p3", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "[E1]p21[/E1] (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the [E2]proliferating cell nuclear antigen[/E2] (PCNA).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[111, 145]], "entity_2_idx_in_text_with_entity_marker": [124, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p4", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "[E1]p21[/E1] (p21WAF1/Cip1), a [E2]cyclin-dependent kinase inhibitor[/E2], induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[22, 55]], "entity_2_idx_in_text_with_entity_marker": [35, 68], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p5", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 (p21WAF1/[E1]Cip1[/E1]), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen ([E2]PCNA[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cip1", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p6", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 ([E1]p21WAF1[/E1]/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen ([E2]PCNA[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21WAF1", "entity_1_idx": [[5, 12]], "entity_1_idx_in_text_with_entity_marker": [9, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p7", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the [E1]proliferating cell nuclear antigen[/E1] ([E2]PCNA[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[111, 145]], "entity_1_idx_in_text_with_entity_marker": [115, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p8", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 (p21WAF1/Cip1), a [E1]cyclin-dependent kinase inhibitor[/E1], induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen ([E2]PCNA[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[22, 55]], "entity_1_idx_in_text_with_entity_marker": [26, 59], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "PCNA", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p9", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 ([E1]p21WAF1[/E1]/[E2]Cip1[/E2]), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21WAF1", "entity_1_idx": [[5, 12]], "entity_1_idx_in_text_with_entity_marker": [9, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cip1", "entity_2_idx": [[13, 17]], "entity_2_idx_in_text_with_entity_marker": [26, 30], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p10", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 (p21WAF1/[E1]Cip1[/E1]), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the [E2]proliferating cell nuclear antigen[/E2] (PCNA).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cip1", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[111, 145]], "entity_2_idx_in_text_with_entity_marker": [124, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p11", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 (p21WAF1/[E1]Cip1[/E1]), a [E2]cyclin-dependent kinase inhibitor[/E2], induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cip1", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[22, 55]], "entity_2_idx_in_text_with_entity_marker": [35, 68], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p12", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 ([E1]p21WAF1[/E1]/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the [E2]proliferating cell nuclear antigen[/E2] (PCNA).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21WAF1", "entity_1_idx": [[5, 12]], "entity_1_idx_in_text_with_entity_marker": [9, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[111, 145]], "entity_2_idx_in_text_with_entity_marker": [124, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p13", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 ([E1]p21WAF1[/E1]/Cip1), a [E2]cyclin-dependent kinase inhibitor[/E2], induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21WAF1", "entity_1_idx": [[5, 12]], "entity_1_idx_in_text_with_entity_marker": [9, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[22, 55]], "entity_2_idx_in_text_with_entity_marker": [35, 68], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d479.s0_BioInfer.d479.s0.p14", "text": "p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).", "text_with_entity_marker": "p21 (p21WAF1/Cip1), a [E1]cyclin-dependent kinase inhibitor[/E1], induces G1 arrest and can inhibit the activity of the [E2]proliferating cell nuclear antigen[/E2] (PCNA).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[22, 55]], "entity_1_idx_in_text_with_entity_marker": [26, 59], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[111, 145]], "entity_2_idx_in_text_with_entity_marker": [124, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d676.s0_BioInfer.d676.s0.p0", "text": "The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.", "text_with_entity_marker": "The proximity of the semi-conserved [E1]actin[/E1]-binding site and the binding pocket characteristic of plant [E2]profilins[/E2] suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[102, 111]], "entity_2_idx_in_text_with_entity_marker": [115, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d676.s0_BioInfer.d676.s0.p1", "text": "The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.", "text_with_entity_marker": "The proximity of the semi-conserved [E1]actin[/E1]-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant [E2]profilins[/E2] thought to be responsible for type I allergies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[241, 250]], "entity_2_idx_in_text_with_entity_marker": [254, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d676.s0_BioInfer.d676.s0.p2", "text": "The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.", "text_with_entity_marker": "The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant [E1]profilins[/E1] suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant [E2]profilins[/E2] thought to be responsible for type I allergies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[102, 111]], "entity_1_idx_in_text_with_entity_marker": [106, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[241, 250]], "entity_2_idx_in_text_with_entity_marker": [254, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p0", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that [E1]actin[/E1] is transported in an unassembled form with its associated proteins actin depolymerizing factor, [E2]cofilin[/E2], and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p1", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that [E1]actin[/E1] is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[141, 149]], "entity_2_idx_in_text_with_entity_marker": [154, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p2", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that [E1]actin[/E1] is transported in an unassembled form with its associated proteins [E2]actin depolymerizing factor[/E2], cofilin, and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[99, 126]], "entity_2_idx_in_text_with_entity_marker": [112, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p3", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, [E1]cofilin[/E1], and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[128, 135]], "entity_1_idx_in_text_with_entity_marker": [132, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[141, 149]], "entity_2_idx_in_text_with_entity_marker": [154, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p4", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that actin is transported in an unassembled form with its associated proteins [E1]actin depolymerizing factor[/E1], [E2]cofilin[/E2], and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[99, 126]], "entity_1_idx_in_text_with_entity_marker": [103, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d817.s0_BioInfer.d817.s0.p5", "text": "We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "We previously showed that actin is transported in an unassembled form with its associated proteins [E1]actin depolymerizing factor[/E1], cofilin, and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[99, 126]], "entity_1_idx_in_text_with_entity_marker": [103, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[141, 149]], "entity_2_idx_in_text_with_entity_marker": [154, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p20", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and RIP and the apoptosis-initiating [E2]caspases-8[/E2] and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases-8", "entity_2_idx": [[102, 112]], "entity_2_idx_in_text_with_entity_marker": [115, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p21", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors[/E2] 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors", "entity_2_idx": [[166, 181], [188, 189]], "entity_2_idx_in_text_with_entity_marker": [179, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p22", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p23", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p24", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p25", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating [E2]caspases[/E2]-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases", "entity_2_idx": [[102, 110], [117, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p26", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating [E2]caspases-8[/E2] and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases-8", "entity_2_idx": [[102, 112]], "entity_2_idx_in_text_with_entity_marker": [115, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p27", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors[/E2] 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors", "entity_2_idx": [[166, 181], [188, 189]], "entity_2_idx_in_text_with_entity_marker": [179, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p28", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p29", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p0", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or [E1]RIP[/E1] suggesting that it is distinct from [E2]FADD[/E2]'s functions at activated death receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[109, 112]], "entity_1_idx_in_text_with_entity_marker": [113, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p1", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, [E1]Fas[/E1], TRADD or [E2]RIP[/E2] suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p2", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of [E1]FADD-DN[/E1]'s ability to bind to three known interacting proteins, Fas, TRADD or [E2]RIP[/E2] suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD-DN", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p3", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or [E1]RIP[/E1] suggesting that it is distinct from FADD's functions at activated [E2]death receptors[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[109, 112]], "entity_1_idx_in_text_with_entity_marker": [113, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "death receptors", "entity_2_idx": [[179, 194]], "entity_2_idx_in_text_with_entity_marker": [192, 207], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p4", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, [E1]TRADD[/E1] or [E2]RIP[/E2] suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p5", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, [E1]Fas[/E1], TRADD or RIP suggesting that it is distinct from [E2]FADD[/E2]'s functions at activated death receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p6", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of [E1]FADD-DN[/E1]'s ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from [E2]FADD[/E2]'s functions at activated death receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD-DN", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p7", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from [E1]FADD[/E1]'s functions at activated [E2]death receptors[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[149, 153]], "entity_1_idx_in_text_with_entity_marker": [153, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "death receptors", "entity_2_idx": [[179, 194]], "entity_2_idx_in_text_with_entity_marker": [192, 207], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p8", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, [E1]TRADD[/E1] or RIP suggesting that it is distinct from [E2]FADD[/E2]'s functions at activated death receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p9", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of [E1]FADD-DN[/E1]'s ability to bind to three known interacting proteins, [E2]Fas[/E2], TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD-DN", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[95, 98]], "entity_2_idx_in_text_with_entity_marker": [108, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p10", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, [E1]Fas[/E1], TRADD or RIP suggesting that it is distinct from FADD's functions at activated [E2]death receptors[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "death receptors", "entity_2_idx": [[179, 194]], "entity_2_idx_in_text_with_entity_marker": [192, 207], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p11", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, [E1]Fas[/E1], [E2]TRADD[/E2] or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p12", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of [E1]FADD-DN[/E1]'s ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated [E2]death receptors[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD-DN", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "death receptors", "entity_2_idx": [[179, 194]], "entity_2_idx_in_text_with_entity_marker": [192, 207], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p13", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of [E1]FADD-DN[/E1]'s ability to bind to three known interacting proteins, Fas, [E2]TRADD[/E2] or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD-DN", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d735.s0_BioInfer.d735.s0.p14", "text": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.", "text_with_entity_marker": "This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, [E1]TRADD[/E1] or RIP suggesting that it is distinct from FADD's functions at activated [E2]death receptors[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "death receptors", "entity_2_idx": [[179, 194]], "entity_2_idx_in_text_with_entity_marker": [192, 207], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p0", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E1]smooth muscle myosin heavy chain[/E1], collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[167, 199]], "entity_1_idx_in_text_with_entity_marker": [171, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p1", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p2", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p3", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p4", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p5", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p6", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E1]high molecular weight caldesmon[/E1], [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "high molecular weight caldesmon", "entity_1_idx": [[134, 165]], "entity_1_idx_in_text_with_entity_marker": [138, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p7", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], high molecular weight caldesmon, [E2]smooth muscle myosin heavy chain[/E2], collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p8", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E1]smooth muscle myosin heavy chain[/E1], [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[167, 199]], "entity_1_idx_in_text_with_entity_marker": [171, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p9", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, [E1]smooth muscle myosin heavy chain[/E1], collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[167, 199]], "entity_1_idx_in_text_with_entity_marker": [171, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p30", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p31", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p32", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p33", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p34", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for [E2]desmin[/E2], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p35", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and [E2]CD34[/E2], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD34", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p36", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E2]high molecular weight caldesmon[/E2], smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "high molecular weight caldesmon", "entity_2_idx": [[134, 165]], "entity_2_idx_in_text_with_entity_marker": [147, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p37", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, [E2]calponin[/E2], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p38", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p39", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d386.s0_BioInfer.d386.s0.p0", "text": "In vitro, actin purified from some of these mutants is defective in polymerization or binding fimbrin.", "text_with_entity_marker": "In vitro, [E1]actin[/E1] purified from some of these mutants is defective in polymerization or binding [E2]fimbrin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p0", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes [E1]MLH1[/E1], MSH2, MSH3, and [E2]MSH6[/E2] (GTBP) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p1", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, [E1]MSH3[/E1], and [E2]MSH6[/E2] (GTBP) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p2", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, [E1]MSH2[/E1], MSH3, and [E2]MSH6[/E2] (GTBP) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[88, 92]], "entity_1_idx_in_text_with_entity_marker": [92, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p3", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and [E1]MSH6[/E1] ([E2]GTBP[/E2]) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[104, 108]], "entity_1_idx_in_text_with_entity_marker": [108, 112], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "GTBP", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p4", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes [E1]MLH1[/E1], MSH2, [E2]MSH3[/E2], and MSH6 (GTBP) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p5", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes [E1]MLH1[/E1], [E2]MSH2[/E2], MSH3, and MSH6 (GTBP) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[88, 92]], "entity_2_idx_in_text_with_entity_marker": [101, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p6", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes [E1]MLH1[/E1], MSH2, MSH3, and MSH6 ([E2]GTBP[/E2]) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "GTBP", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p7", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, [E1]MSH2[/E1], [E2]MSH3[/E2], and MSH6 (GTBP) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[88, 92]], "entity_1_idx_in_text_with_entity_marker": [92, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p8", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, [E1]MSH3[/E1], and MSH6 ([E2]GTBP[/E2]) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "GTBP", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d406.s0_BioInfer.d406.s0.p9", "text": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.", "text_with_entity_marker": "Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, [E1]MSH2[/E1], MSH3, and MSH6 ([E2]GTBP[/E2]) was investigated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[88, 92]], "entity_1_idx_in_text_with_entity_marker": [92, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "GTBP", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d665.s0_BioInfer.d665.s0.p0", "text": "The presence, in varying quantities, of myosin heavy chain and actin isoforms of smooth muscle type in the different vessels reflected their degree of differentiation.", "text_with_entity_marker": "The presence, in varying quantities, of [E1]myosin heavy chain[/E1] and [E2]actin[/E2] isoforms of smooth muscle type in the different vessels reflected their degree of differentiation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[40, 58]], "entity_1_idx_in_text_with_entity_marker": [44, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d703.s0_BioInfer.d703.s0.p0", "text": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes PRP9, PRP11, and PRP21 are their likely yeast counterparts.", "text_with_entity_marker": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes [E1]PRP9[/E1], PRP11, and [E2]PRP21[/E2] are their likely yeast counterparts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP9", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PRP21", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d703.s0_BioInfer.d703.s0.p1", "text": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes PRP9, PRP11, and PRP21 are their likely yeast counterparts.", "text_with_entity_marker": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes PRP9, [E1]PRP11[/E1], and [E2]PRP21[/E2] are their likely yeast counterparts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP11", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PRP21", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d703.s0_BioInfer.d703.s0.p2", "text": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes PRP9, PRP11, and PRP21 are their likely yeast counterparts.", "text_with_entity_marker": "These proteins also compose the essential heterotrimeric splicing factor [E1]SF3a[/E1], and products of yeast pre-mRNA processing genes PRP9, PRP11, and [E2]PRP21[/E2] are their likely yeast counterparts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PRP21", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d703.s0_BioInfer.d703.s0.p3", "text": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes PRP9, PRP11, and PRP21 are their likely yeast counterparts.", "text_with_entity_marker": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes [E1]PRP9[/E1], [E2]PRP11[/E2], and PRP21 are their likely yeast counterparts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP9", "entity_1_idx": [[127, 131]], "entity_1_idx_in_text_with_entity_marker": [131, 135], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PRP11", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d703.s0_BioInfer.d703.s0.p4", "text": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes PRP9, PRP11, and PRP21 are their likely yeast counterparts.", "text_with_entity_marker": "These proteins also compose the essential heterotrimeric splicing factor [E1]SF3a[/E1], and products of yeast pre-mRNA processing genes [E2]PRP9[/E2], PRP11, and PRP21 are their likely yeast counterparts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PRP9", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d703.s0_BioInfer.d703.s0.p5", "text": "These proteins also compose the essential heterotrimeric splicing factor SF3a, and products of yeast pre-mRNA processing genes PRP9, PRP11, and PRP21 are their likely yeast counterparts.", "text_with_entity_marker": "These proteins also compose the essential heterotrimeric splicing factor [E1]SF3a[/E1], and products of yeast pre-mRNA processing genes PRP9, [E2]PRP11[/E2], and PRP21 are their likely yeast counterparts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SF3a", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PRP11", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d160.s0_BioInfer.d160.s0.p0", "text": "Cytoplasmic staining included stress fibers that colocalized with actin, probably as a consequence of the myosin heavy chain component of the fusion protein.", "text_with_entity_marker": "Cytoplasmic staining included stress fibers that colocalized with [E1]actin[/E1], probably as a consequence of the [E2]myosin heavy chain[/E2] component of the fusion protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[106, 124]], "entity_2_idx_in_text_with_entity_marker": [119, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d15.s0_BioInfer.d15.s0.p0", "text": "Actin-binding proteins such as profilins participate in the restructuration of the actin cytoskeleton in plant cells.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as profilins participate in the restructuration of the [E2]actin[/E2] cytoskeleton in plant cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d15.s0_BioInfer.d15.s0.p1", "text": "Actin-binding proteins such as profilins participate in the restructuration of the actin cytoskeleton in plant cells.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as [E2]profilins[/E2] participate in the restructuration of the actin cytoskeleton in plant cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilins", "entity_2_idx": [[31, 40]], "entity_2_idx_in_text_with_entity_marker": [44, 53], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d15.s0_BioInfer.d15.s0.p2", "text": "Actin-binding proteins such as profilins participate in the restructuration of the actin cytoskeleton in plant cells.", "text_with_entity_marker": "Actin-binding proteins such as [E1]profilins[/E1] participate in the restructuration of the [E2]actin[/E2] cytoskeleton in plant cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[31, 40]], "entity_1_idx_in_text_with_entity_marker": [35, 44], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d209.s0_BioInfer.d209.s0.p0", "text": "Finally it was shown that the two isoforms of actin can be separated from each other in the absence of profilin also by chromatography on hydroxyapatite.", "text_with_entity_marker": "Finally it was shown that the two isoforms of [E1]actin[/E1] can be separated from each other in the absence of [E2]profilin[/E2] also by chromatography on hydroxyapatite.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[103, 111]], "entity_2_idx_in_text_with_entity_marker": [116, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p50", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and [E1]H4[/E1], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[60, 62]], "entity_1_idx_in_text_with_entity_marker": [64, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p51", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone [E1]H3[/E1] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[253, 255]], "entity_1_idx_in_text_with_entity_marker": [257, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p52", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E1]H4[/E1] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[180, 182]], "entity_1_idx_in_text_with_entity_marker": [184, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p53", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p54", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, [E1]H3[/E1], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p55", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, [E1]H2B[/E1], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p56", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E1]histone[/E1] H3; histones [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[375, 382]], "entity_1_idx_in_text_with_entity_marker": [379, 386], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p57", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E1]histone[/E1] [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[375, 382]], "entity_1_idx_in_text_with_entity_marker": [379, 386], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p58", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p59", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p10", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/[E1]MORT-1[/E1], RIP) and TRAF domain-containing proteins (TRAF-1, [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT-1", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p11", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/[E1]MORT-1[/E1], RIP) and TRAF domain-containing proteins ([E2]TRAF-1[/E2], TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT-1", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF-1", "entity_2_idx": [[123, 129]], "entity_2_idx_in_text_with_entity_marker": [136, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p12", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/[E1]MORT-1[/E1], RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, [E2]TRAF-3[/E2]) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT-1", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF-3", "entity_2_idx": [[139, 145]], "entity_2_idx_in_text_with_entity_marker": [152, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p13", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], Fas, TRADD, FADD/[E2]MORT-1[/E2], RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MORT-1", "entity_2_idx": [[73, 79]], "entity_2_idx_in_text_with_entity_marker": [86, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p14", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, [E1]TRADD[/E1], FADD/[E2]MORT-1[/E2], RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MORT-1", "entity_2_idx": [[73, 79]], "entity_2_idx_in_text_with_entity_marker": [86, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p15", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], TRADD, FADD/[E2]MORT-1[/E2], RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MORT-1", "entity_2_idx": [[73, 79]], "entity_2_idx_in_text_with_entity_marker": [86, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p16", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/[E1]MORT-1[/E1], [E2]RIP[/E2]) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT-1", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p17", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, [E1]FADD[/E1]/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p18", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, [E1]FADD[/E1]/MORT-1, RIP) and TRAF domain-containing proteins ([E2]TRAF-1[/E2], TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF-1", "entity_2_idx": [[123, 129]], "entity_2_idx_in_text_with_entity_marker": [136, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p19", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, [E1]FADD[/E1]/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, [E2]TRAF-3[/E2]) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF-3", "entity_2_idx": [[139, 145]], "entity_2_idx_in_text_with_entity_marker": [152, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p0", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors ([E1]CKIs[/E1]) [E2]p27[/E2] and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CKIs", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p1", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the [E1]cyclin-dependent kinase inhibitors[/E1] (CKIs) [E2]p27[/E2] and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitors", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p2", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, [E1]cyclin D1[/E1], the cyclin-dependent kinase inhibitors (CKIs) [E2]p27[/E2] and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[135, 144]], "entity_1_idx_in_text_with_entity_marker": [139, 148], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p3", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of [E1]cyclin A[/E1], cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) [E2]p27[/E2] and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin A", "entity_1_idx": [[114, 122]], "entity_1_idx_in_text_with_entity_marker": [118, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p4", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, [E1]cyclin B1[/E1], cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) [E2]p27[/E2] and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin B1", "entity_1_idx": [[124, 133]], "entity_1_idx_in_text_with_entity_marker": [128, 137], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p5", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) [E1]p27[/E1] and [E2]p57[/E2], and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[192, 195]], "entity_1_idx_in_text_with_entity_marker": [196, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[200, 203]], "entity_2_idx_in_text_with_entity_marker": [213, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p6", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the [E1]cyclin-dependent kinase inhibitors[/E1] ([E2]CKIs[/E2]) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitors", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CKIs", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p7", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, [E1]cyclin D1[/E1], the cyclin-dependent kinase inhibitors ([E2]CKIs[/E2]) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[135, 144]], "entity_1_idx_in_text_with_entity_marker": [139, 148], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CKIs", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p8", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of [E1]cyclin A[/E1], cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors ([E2]CKIs[/E2]) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin A", "entity_1_idx": [[114, 122]], "entity_1_idx_in_text_with_entity_marker": [118, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CKIs", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p9", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, [E1]cyclin B1[/E1], cyclin D1, the cyclin-dependent kinase inhibitors ([E2]CKIs[/E2]) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin B1", "entity_1_idx": [[124, 133]], "entity_1_idx_in_text_with_entity_marker": [128, 137], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CKIs", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p10", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors ([E1]CKIs[/E1]) p27 and [E2]p57[/E2], and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CKIs", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p57", "entity_2_idx": [[200, 203]], "entity_2_idx_in_text_with_entity_marker": [213, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p11", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, [E1]cyclin D1[/E1], the [E2]cyclin-dependent kinase inhibitors[/E2] (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[135, 144]], "entity_1_idx_in_text_with_entity_marker": [139, 148], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin-dependent kinase inhibitors", "entity_2_idx": [[150, 184]], "entity_2_idx_in_text_with_entity_marker": [163, 197], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p12", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of [E1]cyclin A[/E1], cyclin B1, cyclin D1, the [E2]cyclin-dependent kinase inhibitors[/E2] (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin A", "entity_1_idx": [[114, 122]], "entity_1_idx_in_text_with_entity_marker": [118, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin-dependent kinase inhibitors", "entity_2_idx": [[150, 184]], "entity_2_idx_in_text_with_entity_marker": [163, 197], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p13", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, [E1]cyclin B1[/E1], cyclin D1, the [E2]cyclin-dependent kinase inhibitors[/E2] (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin B1", "entity_1_idx": [[124, 133]], "entity_1_idx_in_text_with_entity_marker": [128, 137], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin-dependent kinase inhibitors", "entity_2_idx": [[150, 184]], "entity_2_idx_in_text_with_entity_marker": [163, 197], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p14", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the [E1]cyclin-dependent kinase inhibitors[/E1] (CKIs) p27 and [E2]p57[/E2], and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitors", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p57", "entity_2_idx": [[200, 203]], "entity_2_idx_in_text_with_entity_marker": [213, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p15", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of [E1]cyclin A[/E1], cyclin B1, [E2]cyclin D1[/E2], the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin A", "entity_1_idx": [[114, 122]], "entity_1_idx_in_text_with_entity_marker": [118, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin D1", "entity_2_idx": [[135, 144]], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p16", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, [E1]cyclin B1[/E1], [E2]cyclin D1[/E2], the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin B1", "entity_1_idx": [[124, 133]], "entity_1_idx_in_text_with_entity_marker": [128, 137], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin D1", "entity_2_idx": [[135, 144]], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p17", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, [E1]cyclin D1[/E1], the cyclin-dependent kinase inhibitors (CKIs) p27 and [E2]p57[/E2], and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[135, 144]], "entity_1_idx_in_text_with_entity_marker": [139, 148], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p57", "entity_2_idx": [[200, 203]], "entity_2_idx_in_text_with_entity_marker": [213, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p18", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of [E1]cyclin A[/E1], [E2]cyclin B1[/E2], cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin A", "entity_1_idx": [[114, 122]], "entity_1_idx_in_text_with_entity_marker": [118, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin B1", "entity_2_idx": [[124, 133]], "entity_2_idx_in_text_with_entity_marker": [137, 146], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p19", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of [E1]cyclin A[/E1], cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and [E2]p57[/E2], and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin A", "entity_1_idx": [[114, 122]], "entity_1_idx_in_text_with_entity_marker": [118, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p57", "entity_2_idx": [[200, 203]], "entity_2_idx_in_text_with_entity_marker": [213, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d765.s0_BioInfer.d765.s0.p20", "text": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "text_with_entity_marker": "To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, [E1]cyclin B1[/E1], cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and [E2]p57[/E2], and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin B1", "entity_1_idx": [[124, 133]], "entity_1_idx_in_text_with_entity_marker": [128, 137], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p57", "entity_2_idx": [[200, 203]], "entity_2_idx_in_text_with_entity_marker": [213, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p0", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the alpha-catenin-binding region of [E1]beta-catenin[/E1] linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since [E2]beta-catenin[/E2] binding disrupts the alpha-catenin dimer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[60, 72]], "entity_1_idx_in_text_with_entity_marker": [64, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p1", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the alpha-catenin-binding region of [E1]beta-catenin[/E1] linked to the amino terminus of [E2]alpha-catenin 57-264[/E2] behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[60, 72]], "entity_1_idx_in_text_with_entity_marker": [64, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin 57-264", "entity_2_idx": [[105, 125]], "entity_2_idx_in_text_with_entity_marker": [118, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p2", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the alpha-catenin-binding region of [E1]beta-catenin[/E1] linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the [E2]alpha-catenin[/E2] dimer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[60, 72]], "entity_1_idx_in_text_with_entity_marker": [64, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[213, 226]], "entity_2_idx_in_text_with_entity_marker": [226, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p3", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the [E1]alpha-catenin[/E1]-binding region of [E2]beta-catenin[/E2] linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[28, 41]], "entity_1_idx_in_text_with_entity_marker": [32, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[60, 72]], "entity_2_idx_in_text_with_entity_marker": [73, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p4", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of [E1]alpha-catenin 57-264[/E1] behaves as a monomer in solution, as expected, since [E2]beta-catenin[/E2] binding disrupts the alpha-catenin dimer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin 57-264", "entity_1_idx": [[105, 125]], "entity_1_idx_in_text_with_entity_marker": [109, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p5", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since [E1]beta-catenin[/E1] binding disrupts the [E2]alpha-catenin[/E2] dimer.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[179, 191]], "entity_1_idx_in_text_with_entity_marker": [183, 195], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[213, 226]], "entity_2_idx_in_text_with_entity_marker": [226, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p6", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the [E1]alpha-catenin[/E1]-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since [E2]beta-catenin[/E2] binding disrupts the alpha-catenin dimer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[28, 41]], "entity_1_idx_in_text_with_entity_marker": [32, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p7", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of [E1]alpha-catenin 57-264[/E1] behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the [E2]alpha-catenin[/E2] dimer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin 57-264", "entity_1_idx": [[105, 125]], "entity_1_idx_in_text_with_entity_marker": [109, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[213, 226]], "entity_2_idx_in_text_with_entity_marker": [226, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p8", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the [E1]alpha-catenin[/E1]-binding region of beta-catenin linked to the amino terminus of [E2]alpha-catenin 57-264[/E2] behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[28, 41]], "entity_1_idx_in_text_with_entity_marker": [32, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin 57-264", "entity_2_idx": [[105, 125]], "entity_2_idx_in_text_with_entity_marker": [118, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p9", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the [E1]alpha-catenin[/E1]-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the [E2]alpha-catenin[/E2] dimer.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[28, 41]], "entity_1_idx_in_text_with_entity_marker": [32, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[213, 226]], "entity_2_idx_in_text_with_entity_marker": [226, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p0", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "[E1]Actin-depolymerizing factor[/E1] ([E2]ADF[/E2]) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Actin-depolymerizing factor", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[29, 32]], "entity_2_idx_in_text_with_entity_marker": [42, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p1", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "Actin-depolymerizing factor ([E1]ADF[/E1]) and [E2]cofilin[/E2] define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[29, 32]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[38, 45]], "entity_2_idx_in_text_with_entity_marker": [51, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p2", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "Actin-depolymerizing factor ([E1]ADF[/E1]) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous [E2]actin[/E2] in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[29, 32]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p3", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "Actin-depolymerizing factor ([E1]ADF[/E1]) and cofilin define a family of [E2]actin-binding proteins[/E2] essential for the rapid turnover of filamentous actin in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[29, 32]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[65, 87]], "entity_2_idx_in_text_with_entity_marker": [78, 100], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p4", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "[E1]Actin-depolymerizing factor[/E1] (ADF) and [E2]cofilin[/E2] define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Actin-depolymerizing factor", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[38, 45]], "entity_2_idx_in_text_with_entity_marker": [51, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p5", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "[E1]Actin-depolymerizing factor[/E1] (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous [E2]actin[/E2] in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Actin-depolymerizing factor", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p6", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "[E1]Actin-depolymerizing factor[/E1] (ADF) and cofilin define a family of [E2]actin-binding proteins[/E2] essential for the rapid turnover of filamentous actin in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Actin-depolymerizing factor", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[65, 87]], "entity_2_idx_in_text_with_entity_marker": [78, 100], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p7", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "Actin-depolymerizing factor (ADF) and [E1]cofilin[/E1] define a family of actin-binding proteins essential for the rapid turnover of filamentous [E2]actin[/E2] in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[38, 45]], "entity_1_idx_in_text_with_entity_marker": [42, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p8", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "Actin-depolymerizing factor (ADF) and [E1]cofilin[/E1] define a family of [E2]actin-binding proteins[/E2] essential for the rapid turnover of filamentous actin in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[38, 45]], "entity_1_idx_in_text_with_entity_marker": [42, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[65, 87]], "entity_2_idx_in_text_with_entity_marker": [78, 100], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p9", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "Actin-depolymerizing factor (ADF) and cofilin define a family of [E1]actin-binding proteins[/E1] essential for the rapid turnover of filamentous [E2]actin[/E2] in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[65, 87]], "entity_1_idx_in_text_with_entity_marker": [69, 91], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p8", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that [E1]Aip1p[/E1] is a [E2]cofilin[/E2]-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aip1p", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[28, 35]], "entity_2_idx_in_text_with_entity_marker": [41, 48], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p9", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that Aip1p is a [E1]cofilin[/E1]-associated protein that enhances the filament disassembly activity of cofilin and restricts [E2]cofilin[/E2] localization to cortical actin patches.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[28, 35]], "entity_1_idx_in_text_with_entity_marker": [32, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p40", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to [E1]Fas[/E1]/[E2]APO1[/E2] but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[44, 48]], "entity_2_idx_in_text_with_entity_marker": [57, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p41", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/[E1]APO1[/E1] but not to p55-R; another, TRADD, binds to the p55 [E2]TNF receptor[/E2] but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APO1", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[100, 112]], "entity_2_idx_in_text_with_entity_marker": [113, 125], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p42", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/[E1]APO1[/E1] but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, [E2]RIP[/E2], binds weakly to both receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APO1", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p43", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/[E1]APO1[/E1] but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to [E2]Fas[/E2]/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APO1", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p44", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/[E1]APO1[/E1] but not to p55-R; another, TRADD, binds to the [E2]p55[/E2] TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APO1", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p55", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p45", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to [E1]Fas[/E1]/APO1 but not to p55-R; another, TRADD, binds to the p55 [E2]TNF receptor[/E2] but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[100, 112]], "entity_2_idx_in_text_with_entity_marker": [113, 125], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p46", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to [E1]Fas[/E1]/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, [E2]RIP[/E2], binds weakly to both receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p47", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to [E1]Fas[/E1]/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to [E2]Fas[/E2]/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p48", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to [E1]Fas[/E1]/APO1 but not to p55-R; another, TRADD, binds to the [E2]p55[/E2] TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p55", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p49", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 [E1]TNF receptor[/E1] but not to Fas/APO1; and the third, [E2]RIP[/E2], binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF receptor", "entity_1_idx": [[100, 112]], "entity_1_idx_in_text_with_entity_marker": [104, 116], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "RIP", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d460.s0_BioInfer.d460.s0.p0", "text": "One involves talin, which has recently been shown to bind actin directly.", "text_with_entity_marker": "One involves [E1]talin[/E1], which has recently been shown to bind [E2]actin[/E2] directly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p0", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to [E1]P-cadherin[/E1], alpha-catenin, or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P-cadherin", "entity_1_idx": [[159, 169]], "entity_1_idx_in_text_with_entity_marker": [163, 173], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p1", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with [E1]pan-desmocollin[/E1] and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pan-desmocollin", "entity_1_idx": [[194, 209]], "entity_1_idx_in_text_with_entity_marker": [198, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p2", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1], but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p3", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p4", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, [E1]alpha-catenin[/E1], or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[171, 184]], "entity_1_idx_in_text_with_entity_marker": [175, 188], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p5", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p6", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to [E1]P-cadherin[/E1], alpha-catenin, or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P-cadherin", "entity_1_idx": [[159, 169]], "entity_1_idx_in_text_with_entity_marker": [163, 173], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p7", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1], but not with antibodies to [E2]P-cadherin[/E2], alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P-cadherin", "entity_2_idx": [[159, 169]], "entity_2_idx_in_text_with_entity_marker": [172, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p8", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin, but not with antibodies to [E2]P-cadherin[/E2], alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P-cadherin", "entity_2_idx": [[159, 169]], "entity_2_idx_in_text_with_entity_marker": [172, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p9", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to [E1]P-cadherin[/E1], [E2]alpha-catenin[/E2], or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P-cadherin", "entity_1_idx": [[159, 169]], "entity_1_idx_in_text_with_entity_marker": [163, 173], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[171, 184]], "entity_2_idx_in_text_with_entity_marker": [184, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p10", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin, but not with antibodies to [E2]P-cadherin[/E2], alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P-cadherin", "entity_2_idx": [[159, 169]], "entity_2_idx_in_text_with_entity_marker": [172, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p11", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1], but not with antibodies to P-cadherin, alpha-catenin, or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p12", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p13", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, [E1]alpha-catenin[/E1], or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[171, 184]], "entity_1_idx_in_text_with_entity_marker": [175, 188], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p14", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p15", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and [E2]gamma-catenin[/E2], but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[117, 130]], "entity_2_idx_in_text_with_entity_marker": [130, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p16", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1], but not with antibodies to P-cadherin, [E2]alpha-catenin[/E2], or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[171, 184]], "entity_2_idx_in_text_with_entity_marker": [184, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p17", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2], but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[117, 130]], "entity_2_idx_in_text_with_entity_marker": [130, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p18", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, [E2]alpha-catenin[/E2], or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[171, 184]], "entity_2_idx_in_text_with_entity_marker": [184, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p19", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p20", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin, but not with antibodies to P-cadherin, [E2]alpha-catenin[/E2], or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[171, 184]], "entity_2_idx_in_text_with_entity_marker": [184, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s0_BioInfer.d348.s0.p0", "text": "In order to clarify cofilin-dependent regulation of actin assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.", "text_with_entity_marker": "In order to clarify [E1]cofilin[/E1]-dependent regulation of [E2]actin[/E2] assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s0_BioInfer.d348.s0.p1", "text": "In order to clarify cofilin-dependent regulation of actin assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.", "text_with_entity_marker": "In order to clarify cofilin-dependent regulation of [E1]actin[/E1] assembly in muscle cells, [E2]cofilin[/E2] tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[84, 91]], "entity_2_idx_in_text_with_entity_marker": [97, 104], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s0_BioInfer.d348.s0.p2", "text": "In order to clarify cofilin-dependent regulation of actin assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.", "text_with_entity_marker": "In order to clarify [E1]cofilin[/E1]-dependent regulation of actin assembly in muscle cells, [E2]cofilin[/E2] tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[84, 91]], "entity_2_idx_in_text_with_entity_marker": [97, 104], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s1_BioInfer.d348.s1.p0", "text": "The exogeneous cofilin, but not ADF, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.", "text_with_entity_marker": "The exogeneous [E1]cofilin[/E1], but not [E2]ADF[/E2], caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[15, 22]], "entity_1_idx_in_text_with_entity_marker": [19, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[32, 35]], "entity_2_idx_in_text_with_entity_marker": [45, 48], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s1_BioInfer.d348.s1.p1", "text": "The exogeneous cofilin, but not ADF, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.", "text_with_entity_marker": "The exogeneous [E1]cofilin[/E1], but not ADF, caused quick disassembly of [E2]actin[/E2] filaments and accumulated in furrow region of dividing cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[15, 22]], "entity_1_idx_in_text_with_entity_marker": [19, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s1_BioInfer.d348.s1.p2", "text": "The exogeneous cofilin, but not ADF, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.", "text_with_entity_marker": "The exogeneous cofilin, but not [E1]ADF[/E1], caused quick disassembly of [E2]actin[/E2] filaments and accumulated in furrow region of dividing cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s2_BioInfer.d348.s2.p0", "text": "These results suggest that the subcellular distribution of cofilin as well as its interaction with actin in vivo is regulated by its phosphorylation and dephosphorylation.", "text_with_entity_marker": "These results suggest that the subcellular distribution of [E1]cofilin[/E1] as well as its interaction with [E2]actin[/E2] in vivo is regulated by its phosphorylation and dephosphorylation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d356.s0_BioInfer.d356.s0.p0", "text": "Integrating the actin and vimentin cytoskeletons.", "text_with_entity_marker": "Integrating the [E1]actin[/E1] and [E2]vimentin[/E2] cytoskeletons.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[26, 34]], "entity_2_idx_in_text_with_entity_marker": [39, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p20", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the [E1]syntrophin[/E1]-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo [E2]87K[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntrophin", "entity_1_idx": [[188, 198]], "entity_1_idx_in_text_with_entity_marker": [192, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K", "entity_2_idx": [[282, 285]], "entity_2_idx_in_text_with_entity_marker": [295, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p21", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both [E1]beta 2-[/E1] and alpha 1-syntrophin interact with peptides encoding the [E2]syntrophin[/E2]-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 2-", "entity_1_idx": [[121, 128], [141, 151]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntrophin", "entity_2_idx": [[188, 198]], "entity_2_idx_in_text_with_entity_marker": [201, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p22", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E1]dystrophin[/E1], utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[217, 227]], "entity_1_idx_in_text_with_entity_marker": [221, 231], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p23", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E1]dystrophin related protein[/E1], and the Torpedo [E2]87K[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin related protein", "entity_1_idx": [[238, 264]], "entity_1_idx_in_text_with_entity_marker": [242, 268], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K", "entity_2_idx": [[282, 285]], "entity_2_idx_in_text_with_entity_marker": [295, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p24", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both [E1]beta 2-[/E1] and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 2-", "entity_1_idx": [[121, 128], [141, 151]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p25", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E1]dystrophin[/E1], utrophin/dystrophin related protein, and the Torpedo [E2]87K[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[217, 227]], "entity_1_idx_in_text_with_entity_marker": [221, 231], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K", "entity_2_idx": [[282, 285]], "entity_2_idx_in_text_with_entity_marker": [295, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p26", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both [E1]beta 2-[/E1] and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E2]dystrophin[/E2], utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 2-", "entity_1_idx": [[121, 128], [141, 151]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[217, 227]], "entity_2_idx_in_text_with_entity_marker": [230, 240], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p27", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both [E1]beta 2-[/E1] and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo [E2]87K[/E2] protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 2-", "entity_1_idx": [[121, 128], [141, 151]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K", "entity_2_idx": [[282, 285]], "entity_2_idx_in_text_with_entity_marker": [295, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p60", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p61", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p62", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p63", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E1]H[/E1], F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[153, 154], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [157, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p64", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p65", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E1]H[/E1], [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[153, 154], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [157, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p66", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p67", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p68", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p69", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E1]M[/E1]) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[127, 128]], "entity_1_idx_in_text_with_entity_marker": [131, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p70", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p71", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E1]F[/E1], NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[156, 157], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [160, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p72", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p73", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p74", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p75", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E1]M[/E1]) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[127, 128]], "entity_1_idx_in_text_with_entity_marker": [131, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p76", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p77", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p78", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p79", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d156.s0_BioInfer.d156.s0.p0", "text": "Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.", "text_with_entity_marker": "Coprecipitations revealed that transfected cadherin molecules are complexed with [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2] at plasma membranes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d156.s0_BioInfer.d156.s0.p1", "text": "Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.", "text_with_entity_marker": "Coprecipitations revealed that transfected [E1]cadherin[/E1] molecules are complexed with alpha-catenin and [E2]beta-catenin[/E2] at plasma membranes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherin", "entity_1_idx": [[43, 51]], "entity_1_idx_in_text_with_entity_marker": [47, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d156.s0_BioInfer.d156.s0.p2", "text": "Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.", "text_with_entity_marker": "Coprecipitations revealed that transfected [E1]cadherin[/E1] molecules are complexed with [E2]alpha-catenin[/E2] and beta-catenin at plasma membranes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherin", "entity_1_idx": [[43, 51]], "entity_1_idx_in_text_with_entity_marker": [47, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[81, 94]], "entity_2_idx_in_text_with_entity_marker": [94, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p20", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], actin I, profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p21", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], [E2]actin I[/E2], profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin I", "entity_2_idx": [[58, 65]], "entity_2_idx_in_text_with_entity_marker": [71, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p22", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], actin I, [E2]profilins[/E2] Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[67, 76], [86, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p23", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], actin I, profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p24", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], actin I, [E2]profilins I[/E2]a/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins I", "entity_2_idx": [[67, 78], [80, 81]], "entity_2_idx_in_text_with_entity_marker": [80, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p25", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], actin I, profilins Ia/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p26", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], actin I, profilins Ia/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p27", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins Ia[/E1]/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins Ia", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p28", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], [E2]profilins Ia[/E2]/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins Ia", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p29", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1-E2]profilins[/E1] Ia[/E2]/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [74, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins[/E1] Ia", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [74, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p40", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], [E2]profilins[/E2] Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[67, 76], [86, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p41", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p42", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], [E2]profilins I[/E2]a/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins I", "entity_2_idx": [[67, 78], [80, 81]], "entity_2_idx_in_text_with_entity_marker": [80, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p43", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], profilins Ia/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p44", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], profilins Ia/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p45", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins[/E1] Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p46", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1-E2]profilins[/E1] I[/E2]a/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [74, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins[/E1] I", "entity_2_idx": [[67, 78], [80, 81]], "entity_2_idx_in_text_with_entity_marker": [74, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p47", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins[/E1] Ia/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p48", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins[/E1] Ia/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p49", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins I[/E1]a/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins I", "entity_1_idx": [[67, 78], [80, 81]], "entity_1_idx_in_text_with_entity_marker": [71, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d176.s0_BioInfer.d176.s0.p0", "text": "Dispersal of profilin from such sites by oligoproline-rich peptide inhibitors suggests that profilin is directly involved in intracellular pathogen locomotion and reorganization of actin cytoskeleton of the host cell peripheral membrane.", "text_with_entity_marker": "Dispersal of [E1]profilin[/E1] from such sites by oligoproline-rich peptide inhibitors suggests that profilin is directly involved in intracellular pathogen locomotion and reorganization of [E2]actin[/E2] cytoskeleton of the host cell peripheral membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[181, 186]], "entity_2_idx_in_text_with_entity_marker": [194, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d176.s0_BioInfer.d176.s0.p1", "text": "Dispersal of profilin from such sites by oligoproline-rich peptide inhibitors suggests that profilin is directly involved in intracellular pathogen locomotion and reorganization of actin cytoskeleton of the host cell peripheral membrane.", "text_with_entity_marker": "Dispersal of profilin from such sites by oligoproline-rich peptide inhibitors suggests that [E1]profilin[/E1] is directly involved in intracellular pathogen locomotion and reorganization of [E2]actin[/E2] cytoskeleton of the host cell peripheral membrane.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[92, 100]], "entity_1_idx_in_text_with_entity_marker": [96, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[181, 186]], "entity_2_idx_in_text_with_entity_marker": [194, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d176.s0_BioInfer.d176.s0.p2", "text": "Dispersal of profilin from such sites by oligoproline-rich peptide inhibitors suggests that profilin is directly involved in intracellular pathogen locomotion and reorganization of actin cytoskeleton of the host cell peripheral membrane.", "text_with_entity_marker": "Dispersal of [E1]profilin[/E1] from such sites by oligoproline-rich peptide inhibitors suggests that [E2]profilin[/E2] is directly involved in intracellular pathogen locomotion and reorganization of actin cytoskeleton of the host cell peripheral membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[92, 100]], "entity_2_idx_in_text_with_entity_marker": [105, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p10", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], myosin heavy chain, sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p11", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E1]myosin heavy chain[/E1], sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[136, 154]], "entity_1_idx_in_text_with_entity_marker": [140, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p12", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p13", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p14", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p15", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, [E1]sarcomeric actin[/E1], [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sarcomeric actin", "entity_1_idx": [[156, 172]], "entity_1_idx_in_text_with_entity_marker": [160, 176], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p16", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], myosin heavy chain, [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p17", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E1]myosin heavy chain[/E1], [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[136, 154]], "entity_1_idx_in_text_with_entity_marker": [140, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p18", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p19", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, myosin heavy chain, [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p10", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the [E1]srs2[/E1] rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2", "entity_1_idx": [[200, 204]], "entity_1_idx_in_text_with_entity_marker": [204, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p11", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p12", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p13", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E1]MEC3[/E1], indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p14", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p15", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p16", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p17", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p18", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p19", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E1]rad54[/E1] and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad54", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p20", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 [E1]rad54[/E1] and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad54", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p21", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p22", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and [E2]MEC3[/E2], indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p23", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p24", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p25", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p26", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p27", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E2]RAD24[/E2], and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p28", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p29", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p50", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p51", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] [E2]rad54Delta[/E2] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54Delta", "entity_2_idx": [[27, 37]], "entity_2_idx_in_text_with_entity_marker": [40, 50], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p52", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and [E2]srs2Delta[/E2] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2Delta", "entity_2_idx": [[42, 51]], "entity_2_idx_in_text_with_entity_marker": [55, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p53", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta [E2]rdh54Delta[/E2] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54Delta", "entity_2_idx": [[52, 62]], "entity_2_idx_in_text_with_entity_marker": [65, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p54", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p55", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p56", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and [E2]srs2Delta[/E2] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2Delta", "entity_2_idx": [[42, 51]], "entity_2_idx_in_text_with_entity_marker": [55, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p57", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta [E2]rdh54Delta[/E2] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54Delta", "entity_2_idx": [[52, 62]], "entity_2_idx_in_text_with_entity_marker": [65, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p58", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p59", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d472.s0_BioInfer.d472.s0.p0", "text": "Our data indicate that even profilins of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, profilins are engaged in regulating either the stability or the kinetic properties of actin filaments.", "text_with_entity_marker": "Our data indicate that even [E1]profilins[/E1] of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, [E2]profilins[/E2] are engaged in regulating either the stability or the kinetic properties of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[28, 37]], "entity_1_idx_in_text_with_entity_marker": [32, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[168, 177]], "entity_2_idx_in_text_with_entity_marker": [181, 190], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d472.s0_BioInfer.d472.s0.p1", "text": "Our data indicate that even profilins of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, profilins are engaged in regulating either the stability or the kinetic properties of actin filaments.", "text_with_entity_marker": "Our data indicate that even profilins of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, [E1]profilins[/E1] are engaged in regulating either the stability or the kinetic properties of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[168, 177]], "entity_1_idx_in_text_with_entity_marker": [172, 181], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[254, 259]], "entity_2_idx_in_text_with_entity_marker": [267, 272], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d472.s0_BioInfer.d472.s0.p2", "text": "Our data indicate that even profilins of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, profilins are engaged in regulating either the stability or the kinetic properties of actin filaments.", "text_with_entity_marker": "Our data indicate that even [E1]profilins[/E1] of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, profilins are engaged in regulating either the stability or the kinetic properties of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[28, 37]], "entity_1_idx_in_text_with_entity_marker": [32, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[254, 259]], "entity_2_idx_in_text_with_entity_marker": [267, 272], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d445.s0_BioInfer.d445.s0.p0", "text": "Mutations in RAD27 cause increased rates of mitotic crossing over and are lethal in combination with mutations in RAD51 and RAD52.", "text_with_entity_marker": "Mutations in [E1]RAD27[/E1] cause increased rates of mitotic crossing over and are lethal in combination with mutations in [E2]RAD51[/E2] and RAD52.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD27", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d445.s0_BioInfer.d445.s0.p1", "text": "Mutations in RAD27 cause increased rates of mitotic crossing over and are lethal in combination with mutations in RAD51 and RAD52.", "text_with_entity_marker": "Mutations in RAD27 cause increased rates of mitotic crossing over and are lethal in combination with mutations in [E1]RAD51[/E1] and [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d445.s0_BioInfer.d445.s0.p2", "text": "Mutations in RAD27 cause increased rates of mitotic crossing over and are lethal in combination with mutations in RAD51 and RAD52.", "text_with_entity_marker": "Mutations in [E1]RAD27[/E1] cause increased rates of mitotic crossing over and are lethal in combination with mutations in RAD51 and [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD27", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s0_BioInfer.d43.s0.p0", "text": "Although co-localization of glucokinase with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.", "text_with_entity_marker": "Although co-localization of [E1]glucokinase[/E1] with [E2]actin[/E2] filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "glucokinase", "entity_1_idx": [[28, 39]], "entity_1_idx_in_text_with_entity_marker": [32, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s0_BioInfer.d43.s0.p1", "text": "Although co-localization of glucokinase with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.", "text_with_entity_marker": "Although co-localization of glucokinase with [E1]actin[/E1] filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, [E2]islet glucokinase[/E2] was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "islet glucokinase", "entity_2_idx": [[129, 146]], "entity_2_idx_in_text_with_entity_marker": [142, 159], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s0_BioInfer.d43.s0.p2", "text": "Although co-localization of glucokinase with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.", "text_with_entity_marker": "Although co-localization of [E1]glucokinase[/E1] with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, [E2]islet glucokinase[/E2] was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glucokinase", "entity_1_idx": [[28, 39]], "entity_1_idx_in_text_with_entity_marker": [32, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "islet glucokinase", "entity_2_idx": [[129, 146]], "entity_2_idx_in_text_with_entity_marker": [142, 159], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s1_BioInfer.d43.s1.p0", "text": "A portion of glucokinase appeared to be co-localized with actin filaments in the cytoplasm of cultured rat hepatocytes incubated with 25 mM glucose.", "text_with_entity_marker": "A portion of [E1]glucokinase[/E1] appeared to be co-localized with [E2]actin[/E2] filaments in the cytoplasm of cultured rat hepatocytes incubated with 25 mM glucose.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "glucokinase", "entity_1_idx": [[13, 24]], "entity_1_idx_in_text_with_entity_marker": [17, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s2_BioInfer.d43.s2.p0", "text": "Co-localization of glucokinase with actin filaments.", "text_with_entity_marker": "Co-localization of [E1]glucokinase[/E1] with [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "glucokinase", "entity_1_idx": [[19, 30]], "entity_1_idx_in_text_with_entity_marker": [23, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s3_BioInfer.d43.s3.p0", "text": "When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "text_with_entity_marker": "When liver- or [E1]islet-type glucokinase[/E1] was transiently expressed in COS-7 cells, the expressed [E2]glucokinase[/E2] was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "islet-type glucokinase", "entity_1_idx": [[15, 37]], "entity_1_idx_in_text_with_entity_marker": [19, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glucokinase", "entity_2_idx": [[94, 105]], "entity_2_idx_in_text_with_entity_marker": [107, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s3_BioInfer.d43.s3.p1", "text": "When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "text_with_entity_marker": "When [E1]liver-[/E1] or [E2]islet-type glucokinase[/E2] was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "liver-", "entity_1_idx": [[5, 11], [21, 37]], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "islet-type glucokinase", "entity_2_idx": [[15, 37]], "entity_2_idx_in_text_with_entity_marker": [28, 50], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s3_BioInfer.d43.s3.p2", "text": "When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "text_with_entity_marker": "When liver- or [E1]islet-type glucokinase[/E1] was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with [E2]actin[/E2] filaments in the cytoplasm of these transfected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "islet-type glucokinase", "entity_1_idx": [[15, 37]], "entity_1_idx_in_text_with_entity_marker": [19, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s3_BioInfer.d43.s3.p3", "text": "When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "text_with_entity_marker": "When [E1]liver-[/E1] or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed [E2]glucokinase[/E2] was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "liver-", "entity_1_idx": [[5, 11], [21, 37]], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glucokinase", "entity_2_idx": [[94, 105]], "entity_2_idx_in_text_with_entity_marker": [107, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s3_BioInfer.d43.s3.p4", "text": "When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "text_with_entity_marker": "When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed [E1]glucokinase[/E1] was also co-localized with [E2]actin[/E2] filaments in the cytoplasm of these transfected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "glucokinase", "entity_1_idx": [[94, 105]], "entity_1_idx_in_text_with_entity_marker": [98, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d43.s3_BioInfer.d43.s3.p5", "text": "When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.", "text_with_entity_marker": "When [E1]liver-[/E1] or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with [E2]actin[/E2] filaments in the cytoplasm of these transfected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "liver-", "entity_1_idx": [[5, 11], [21, 37]], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d537.s0_BioInfer.d537.s0.p0", "text": "Signaling pathways involved in dephosphorylation and localization of the actin-binding protein cofilin in stimulated human neutrophils.", "text_with_entity_marker": "Signaling pathways involved in dephosphorylation and localization of the [E1]actin-binding protein[/E1] [E2]cofilin[/E2] in stimulated human neutrophils.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[73, 94]], "entity_1_idx_in_text_with_entity_marker": [77, 98], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[95, 102]], "entity_2_idx_in_text_with_entity_marker": [108, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d537.s1_BioInfer.d537.s1.p0", "text": "These findings suggest a role of cofilin in stimulus-dependent actin remodeling in motile neutrophils.", "text_with_entity_marker": "These findings suggest a role of [E1]cofilin[/E1] in stimulus-dependent [E2]actin[/E2] remodeling in motile neutrophils.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d464.s0_BioInfer.d464.s0.p0", "text": "Only the unphosphorylated form of cofilin is an active form that binds actin, whereas the regulatory mechanisms of cofilin have not been elucidated.", "text_with_entity_marker": "Only the unphosphorylated form of cofilin is an active form that binds [E1]actin[/E1], whereas the regulatory mechanisms of [E2]cofilin[/E2] have not been elucidated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d464.s0_BioInfer.d464.s0.p1", "text": "Only the unphosphorylated form of cofilin is an active form that binds actin, whereas the regulatory mechanisms of cofilin have not been elucidated.", "text_with_entity_marker": "Only the unphosphorylated form of [E1]cofilin[/E1] is an active form that binds actin, whereas the regulatory mechanisms of [E2]cofilin[/E2] have not been elucidated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d464.s0_BioInfer.d464.s0.p2", "text": "Only the unphosphorylated form of cofilin is an active form that binds actin, whereas the regulatory mechanisms of cofilin have not been elucidated.", "text_with_entity_marker": "Only the unphosphorylated form of [E1]cofilin[/E1] is an active form that binds [E2]actin[/E2], whereas the regulatory mechanisms of cofilin have not been elucidated.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d21.s0_BioInfer.d21.s0.p0", "text": "Actophorin and profilin have opposite effects on the rate of exchange of nucleotide bound to actin monomers.", "text_with_entity_marker": "Actophorin and [E1]profilin[/E1] have opposite effects on the rate of exchange of nucleotide bound to [E2]actin[/E2] monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d21.s0_BioInfer.d21.s0.p1", "text": "Actophorin and profilin have opposite effects on the rate of exchange of nucleotide bound to actin monomers.", "text_with_entity_marker": "[E1]Actophorin[/E1] and profilin have opposite effects on the rate of exchange of nucleotide bound to [E2]actin[/E2] monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Actophorin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d21.s0_BioInfer.d21.s0.p2", "text": "Actophorin and profilin have opposite effects on the rate of exchange of nucleotide bound to actin monomers.", "text_with_entity_marker": "[E1]Actophorin[/E1] and [E2]profilin[/E2] have opposite effects on the rate of exchange of nucleotide bound to actin monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Actophorin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[15, 23]], "entity_2_idx_in_text_with_entity_marker": [28, 36], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p10", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha ([E1]IL-1alpha[/E1]) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IL-1alpha", "entity_1_idx": [[176, 185]], "entity_1_idx_in_text_with_entity_marker": [180, 189], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p11", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage [E1]collagen[/E1] breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "collagen", "entity_1_idx": [[207, 215]], "entity_1_idx_in_text_with_entity_marker": [211, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p12", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other [E1]glycoprotein 130[/E1] (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glycoprotein 130", "entity_1_idx": [[38, 54]], "entity_1_idx_in_text_with_entity_marker": [42, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p13", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M ([E1]OSM[/E1]) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OSM", "entity_1_idx": [[120, 123]], "entity_1_idx_in_text_with_entity_marker": [124, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p14", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 ([E1]gp130[/E1]) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gp130", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p15", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding [E1]cytokines[/E1] can mimic the effects of oncostatin M (OSM) in acting synergistically with [E2]interleukin-1alpha[/E2] (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cytokines", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "interleukin-1alpha", "entity_2_idx": [[156, 174]], "entity_2_idx_in_text_with_entity_marker": [169, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p16", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding [E1]cytokines[/E1] can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha ([E2]IL-1alpha[/E2]) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cytokines", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "IL-1alpha", "entity_2_idx": [[176, 185]], "entity_2_idx_in_text_with_entity_marker": [189, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p17", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding [E1]cytokines[/E1] can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage [E2]collagen[/E2] breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cytokines", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "collagen", "entity_2_idx": [[207, 215]], "entity_2_idx_in_text_with_entity_marker": [220, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p18", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other [E1]glycoprotein 130[/E1] (gp130) binding [E2]cytokines[/E2] can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "glycoprotein 130", "entity_1_idx": [[38, 54]], "entity_1_idx_in_text_with_entity_marker": [42, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokines", "entity_2_idx": [[71, 80]], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p19", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding [E1]cytokines[/E1] can mimic the effects of oncostatin M ([E2]OSM[/E2]) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokines", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "OSM", "entity_2_idx": [[120, 123]], "entity_2_idx_in_text_with_entity_marker": [133, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p0", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of UBE2I with RAD52, [E1]UBL1[/E1], p53, and [E2]RAD51[/E2] proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UBL1", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p1", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of UBE2I with [E1]RAD52[/E1], [E2]UBL1[/E2], p53, and RAD51 proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UBL1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p2", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of [E1]UBE2I[/E1] with RAD52, [E2]UBL1[/E2], p53, and RAD51 proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UBE2I", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UBL1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p3", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of UBE2I with RAD52, [E1]UBL1[/E1], [E2]p53[/E2], and RAD51 proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UBL1", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p4", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of UBE2I with [E1]RAD52[/E1], UBL1, p53, and [E2]RAD51[/E2] proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p5", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of [E1]UBE2I[/E1] with RAD52, UBL1, p53, and [E2]RAD51[/E2] proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UBE2I", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p6", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of UBE2I with RAD52, UBL1, [E1]p53[/E1], and [E2]RAD51[/E2] proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p7", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of [E1]UBE2I[/E1] with [E2]RAD52[/E2], UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UBE2I", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p8", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of UBE2I with [E1]RAD52[/E1], UBL1, [E2]p53[/E2], and RAD51 proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p9", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of [E1]UBE2I[/E1] with RAD52, UBL1, [E2]p53[/E2], and RAD51 proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UBE2I", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p0", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas [E1]SIR2[/E1], SIR3, and [E2]SIR4[/E2] are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[163, 167]], "entity_1_idx_in_text_with_entity_marker": [167, 171], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p1", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that [E1]SIR1[/E1] protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas [E2]SIR2[/E2], SIR3, and SIR4 are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR2", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p2", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas [E1]SIR2[/E1], [E2]SIR3[/E2], and SIR4 are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[163, 167]], "entity_1_idx_in_text_with_entity_marker": [167, 171], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR3", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p3", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that [E1]SIR1[/E1] protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and [E2]SIR4[/E2] are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p4", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, [E1]SIR3[/E1], and [E2]SIR4[/E2] are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR3", "entity_1_idx": [[169, 173]], "entity_1_idx_in_text_with_entity_marker": [173, 177], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d56.s0_BioInfer.d56.s0.p5", "text": "Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.", "text_with_entity_marker": "Analysis of changes in state suggests that [E1]SIR1[/E1] protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, [E2]SIR3[/E2], and SIR4 are required for maintenance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR3", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p0", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27([E2]Kip1[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[133, 166]], "entity_1_idx_in_text_with_entity_marker": [137, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Kip1", "entity_2_idx": [[171, 175]], "entity_2_idx_in_text_with_entity_marker": [184, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p1", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of insulin appears to involve increases in the expression of [E1]cyclin E[/E1] and decreases in the expression of the [E2]cyclin-dependent kinase inhibitor[/E2] p27(Kip1).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[85, 93]], "entity_1_idx_in_text_with_entity_marker": [89, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[133, 166]], "entity_2_idx_in_text_with_entity_marker": [146, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p2", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of [E1]insulin[/E1] appears to involve increases in the expression of cyclin E and decreases in the expression of the [E2]cyclin-dependent kinase inhibitor[/E2] p27(Kip1).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[133, 166]], "entity_2_idx_in_text_with_entity_marker": [146, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p3", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p27[/E2](Kip1).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[133, 166]], "entity_1_idx_in_text_with_entity_marker": [137, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[167, 170]], "entity_2_idx_in_text_with_entity_marker": [180, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p4", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of insulin appears to involve increases in the expression of [E1]cyclin E[/E1] and decreases in the expression of the cyclin-dependent kinase inhibitor p27([E2]Kip1[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[85, 93]], "entity_1_idx_in_text_with_entity_marker": [89, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Kip1", "entity_2_idx": [[171, 175]], "entity_2_idx_in_text_with_entity_marker": [184, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p5", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of [E1]insulin[/E1] appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27([E2]Kip1[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Kip1", "entity_2_idx": [[171, 175]], "entity_2_idx_in_text_with_entity_marker": [184, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p6", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1]([E2]Kip1[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[167, 170]], "entity_1_idx_in_text_with_entity_marker": [171, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Kip1", "entity_2_idx": [[171, 175]], "entity_2_idx_in_text_with_entity_marker": [184, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p7", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of [E1]insulin[/E1] appears to involve increases in the expression of [E2]cyclin E[/E2] and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[85, 93]], "entity_2_idx_in_text_with_entity_marker": [98, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p8", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of insulin appears to involve increases in the expression of [E1]cyclin E[/E1] and decreases in the expression of the cyclin-dependent kinase inhibitor [E2]p27[/E2](Kip1).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[85, 93]], "entity_1_idx_in_text_with_entity_marker": [89, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[167, 170]], "entity_2_idx_in_text_with_entity_marker": [180, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d663.s0_BioInfer.d663.s0.p9", "text": "The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).", "text_with_entity_marker": "The potentiating effect of [E1]insulin[/E1] appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor [E2]p27[/E2](Kip1).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[167, 170]], "entity_2_idx_in_text_with_entity_marker": [180, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p0", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and [E1]alpha-catenin[/E1], as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the [E2]alpha-[/E2] and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[37, 50]], "entity_1_idx_in_text_with_entity_marker": [41, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-", "entity_2_idx": [[161, 167], [177, 184]], "entity_2_idx_in_text_with_entity_marker": [174, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p1", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the [E1]alpha-[/E1] and [E2]beta-catenin[/E2] genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-", "entity_1_idx": [[161, 167], [177, 184]], "entity_1_idx_in_text_with_entity_marker": [165, 171], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p2", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1] and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the [E2]alpha-[/E2] and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-", "entity_2_idx": [[161, 167], [177, 184]], "entity_2_idx_in_text_with_entity_marker": [174, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p3", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the [E1]E-cadherin[/E1] gene, have been found in various carcinomas, whereas mutations in the [E2]alpha-[/E2] and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[80, 90]], "entity_1_idx_in_text_with_entity_marker": [84, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-", "entity_2_idx": [[161, 167], [177, 184]], "entity_2_idx_in_text_with_entity_marker": [174, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p4", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and [E1]alpha-catenin[/E1], as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and [E2]beta-catenin[/E2] genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[37, 50]], "entity_1_idx_in_text_with_entity_marker": [41, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p5", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2], as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[37, 50]], "entity_2_idx_in_text_with_entity_marker": [50, 63], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p6", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and [E1]alpha-catenin[/E1], as well as mutations in the [E2]E-cadherin[/E2] gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[37, 50]], "entity_1_idx_in_text_with_entity_marker": [41, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[80, 90]], "entity_2_idx_in_text_with_entity_marker": [93, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p7", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1] and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and [E2]beta-catenin[/E2] genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p8", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the [E1]E-cadherin[/E1] gene, have been found in various carcinomas, whereas mutations in the alpha- and [E2]beta-catenin[/E2] genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[80, 90]], "entity_1_idx_in_text_with_entity_marker": [84, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p9", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1] and alpha-catenin, as well as mutations in the [E2]E-cadherin[/E2] gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[80, 90]], "entity_2_idx_in_text_with_entity_marker": [93, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p0", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit [E1]p300[/E1] (and the highly related molecule, CREB-binding protein, or CBP) [E2]histone[/E2] acetylation activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[115, 119]], "entity_1_idx_in_text_with_entity_marker": [119, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[184, 191]], "entity_2_idx_in_text_with_entity_marker": [197, 204], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p1", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit [E1]p300[/E1] (and the highly related molecule, [E2]CREB-binding protein[/E2], or CBP) histone acetylation activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[115, 119]], "entity_1_idx_in_text_with_entity_marker": [119, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB-binding protein", "entity_2_idx": [[154, 174]], "entity_2_idx_in_text_with_entity_marker": [167, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p2", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit [E1]p300[/E1] (and the highly related molecule, CREB-binding protein, or [E2]CBP[/E2]) histone acetylation activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[115, 119]], "entity_1_idx_in_text_with_entity_marker": [119, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p3", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that [E1]EID-1[/E1] is a potent inhibitor of differentiation and link this activity to its ability to inhibit [E2]p300[/E2] (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EID-1", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p4", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, [E1]CREB-binding protein[/E1], or CBP) [E2]histone[/E2] acetylation activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CREB-binding protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[184, 191]], "entity_2_idx_in_text_with_entity_marker": [197, 204], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p5", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or [E1]CBP[/E1]) [E2]histone[/E2] acetylation activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[179, 182]], "entity_1_idx_in_text_with_entity_marker": [183, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[184, 191]], "entity_2_idx_in_text_with_entity_marker": [197, 204], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p6", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that [E1]EID-1[/E1] is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) [E2]histone[/E2] acetylation activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EID-1", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[184, 191]], "entity_2_idx_in_text_with_entity_marker": [197, 204], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p7", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, [E1]CREB-binding protein[/E1], or [E2]CBP[/E2]) histone acetylation activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB-binding protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p8", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that [E1]EID-1[/E1] is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, [E2]CREB-binding protein[/E2], or CBP) histone acetylation activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EID-1", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB-binding protein", "entity_2_idx": [[154, 174]], "entity_2_idx_in_text_with_entity_marker": [167, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d251.s0_BioInfer.d251.s0.p9", "text": "Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.", "text_with_entity_marker": "Here, we show that [E1]EID-1[/E1] is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or [E2]CBP[/E2]) histone acetylation activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EID-1", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s4_BioInfer.d570.s4.p0", "text": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human profilin and rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human [E1]profilin[/E1] and rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[139, 147]], "entity_1_idx_in_text_with_entity_marker": [143, 151], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[159, 180]], "entity_2_idx_in_text_with_entity_marker": [172, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s4_BioInfer.d570.s4.p1", "text": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human profilin and rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human profilin and rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[159, 180]], "entity_2_idx_in_text_with_entity_marker": [172, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s4_BioInfer.d570.s4.p2", "text": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human profilin and rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast [E1]actin[/E1] almost 2 orders of magnitude less efficiently than human profilin and rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[159, 180]], "entity_2_idx_in_text_with_entity_marker": [172, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s4_BioInfer.d570.s4.p3", "text": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human profilin and rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human [E2]profilin[/E2] and rabbit skeletal muscle actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s4_BioInfer.d570.s4.p4", "text": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human profilin and rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast [E1]actin[/E1] almost 2 orders of magnitude less efficiently than human [E2]profilin[/E2] and rabbit skeletal muscle actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s4_BioInfer.d570.s4.p5", "text": "Yeast profilin was shown to catalyze adenine nucleotide exchange from yeast actin almost 2 orders of magnitude less efficiently than human profilin and rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] was shown to catalyze adenine nucleotide exchange from yeast [E2]actin[/E2] almost 2 orders of magnitude less efficiently than human profilin and rabbit skeletal muscle actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d88.s0_BioInfer.d88.s0.p0", "text": "At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins villin and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.", "text_with_entity_marker": "At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins [E1]villin[/E1] and [E2]fimbrin[/E2] that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[124, 130]], "entity_1_idx_in_text_with_entity_marker": [128, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d88.s0_BioInfer.d88.s0.p1", "text": "At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins villin and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.", "text_with_entity_marker": "At the light microscope level, brush cells can be identified by antibodies against the [E1]actin[/E1] filament crosslinking proteins [E2]villin[/E2] and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "villin", "entity_2_idx": [[124, 130]], "entity_2_idx_in_text_with_entity_marker": [137, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d88.s0_BioInfer.d88.s0.p2", "text": "At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins villin and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.", "text_with_entity_marker": "At the light microscope level, brush cells can be identified by antibodies against the [E1]actin[/E1] filament crosslinking proteins villin and [E2]fimbrin[/E2] that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d520.s0_BioInfer.d520.s0.p0", "text": "Requirement of yeast fimbrin for actin organization and morphogenesis in vivo.", "text_with_entity_marker": "Requirement of yeast [E1]fimbrin[/E1] for [E2]actin[/E2] organization and morphogenesis in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[21, 28]], "entity_1_idx_in_text_with_entity_marker": [25, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d683.s0_BioInfer.d683.s0.p0", "text": "The recombinant material is similar to authentic human platelet profilin based on the measured Kd for rabbit skeletal muscle actin.", "text_with_entity_marker": "The recombinant material is similar to authentic human [E1]platelet profilin[/E1] based on the measured Kd for rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "platelet profilin", "entity_1_idx": [[55, 72]], "entity_1_idx_in_text_with_entity_marker": [59, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[109, 130]], "entity_2_idx_in_text_with_entity_marker": [122, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d154.s0_BioInfer.d154.s0.p0", "text": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "text_with_entity_marker": "Conversely, inhibition of [E1]LIMK[/E1]'s activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of [E2]actin[/E2] filaments at the phagocytic cup and also inhibits phagocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d154.s0_BioInfer.d154.s0.p1", "text": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "text_with_entity_marker": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A [E1]cofilin[/E1] mutant induces loss of [E2]actin[/E2] filaments at the phagocytic cup and also inhibits phagocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[142, 149]], "entity_1_idx_in_text_with_entity_marker": [146, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d154.s0_BioInfer.d154.s0.p2", "text": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "text_with_entity_marker": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, [E1]LIMK1-[/E1], or expression of the constitutively active S3A cofilin mutant induces loss of [E2]actin[/E2] filaments at the phagocytic cup and also inhibits phagocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK1-", "entity_1_idx": [[87, 93]], "entity_1_idx_in_text_with_entity_marker": [91, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d154.s0_BioInfer.d154.s0.p3", "text": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "text_with_entity_marker": "Conversely, inhibition of [E1]LIMK[/E1]'s activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A [E2]cofilin[/E2] mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIMK", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[142, 149]], "entity_2_idx_in_text_with_entity_marker": [155, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d154.s0_BioInfer.d154.s0.p4", "text": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "text_with_entity_marker": "Conversely, inhibition of [E1]LIMK[/E1]'s activity by expressing a dominant negative construct, [E2]LIMK1-[/E2], or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK1-", "entity_2_idx": [[87, 93]], "entity_2_idx_in_text_with_entity_marker": [100, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d154.s0_BioInfer.d154.s0.p5", "text": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "text_with_entity_marker": "Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, [E1]LIMK1-[/E1], or expression of the constitutively active S3A [E2]cofilin[/E2] mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIMK1-", "entity_1_idx": [[87, 93]], "entity_1_idx_in_text_with_entity_marker": [91, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[142, 149]], "entity_2_idx_in_text_with_entity_marker": [155, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p0", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, [E1]alpha-actinin[/E1] and [E2]vinculin[/E2] that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-actinin", "entity_1_idx": [[143, 156]], "entity_1_idx_in_text_with_entity_marker": [147, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[161, 169]], "entity_2_idx_in_text_with_entity_marker": [174, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p1", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], p120, [E2]alpha-actinin[/E2] and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[124, 135]], "entity_1_idx_in_text_with_entity_marker": [128, 139], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-actinin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p2", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, [E1]p120[/E1], [E2]alpha-actinin[/E2] and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[137, 141]], "entity_1_idx_in_text_with_entity_marker": [141, 145], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-actinin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p3", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, p120, [E2]alpha-actinin[/E2] and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[95, 108]], "entity_1_idx_in_text_with_entity_marker": [99, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-actinin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p4", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, p120, [E2]alpha-actinin[/E2] and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[110, 122]], "entity_1_idx_in_text_with_entity_marker": [114, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-actinin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p5", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, p120, [E2]alpha-actinin[/E2] and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-actinin", "entity_2_idx": [[143, 156]], "entity_2_idx_in_text_with_entity_marker": [156, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p6", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], p120, alpha-actinin and [E2]vinculin[/E2] that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[124, 135]], "entity_1_idx_in_text_with_entity_marker": [128, 139], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[161, 169]], "entity_2_idx_in_text_with_entity_marker": [174, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p7", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, [E1]p120[/E1], alpha-actinin and [E2]vinculin[/E2] that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[137, 141]], "entity_1_idx_in_text_with_entity_marker": [141, 145], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[161, 169]], "entity_2_idx_in_text_with_entity_marker": [174, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p8", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, p120, alpha-actinin and [E2]vinculin[/E2] that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[95, 108]], "entity_1_idx_in_text_with_entity_marker": [99, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[161, 169]], "entity_2_idx_in_text_with_entity_marker": [174, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p9", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, p120, alpha-actinin and [E2]vinculin[/E2] that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[110, 122]], "entity_1_idx_in_text_with_entity_marker": [114, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[161, 169]], "entity_2_idx_in_text_with_entity_marker": [174, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p10", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and [E2]vinculin[/E2] that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[161, 169]], "entity_2_idx_in_text_with_entity_marker": [174, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p11", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], [E2]p120[/E2], alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[124, 135]], "entity_1_idx_in_text_with_entity_marker": [128, 139], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p12", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, [E1]alpha-catenin[/E1], beta-catenin, [E2]plakoglobin[/E2], p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[95, 108]], "entity_1_idx_in_text_with_entity_marker": [99, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p13", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[110, 122]], "entity_1_idx_in_text_with_entity_marker": [114, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p14", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p15", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, [E2]p120[/E2], alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[95, 108]], "entity_1_idx_in_text_with_entity_marker": [99, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p16", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, [E2]p120[/E2], alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[110, 122]], "entity_1_idx_in_text_with_entity_marker": [114, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p17", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, [E2]p120[/E2], alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p18", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[95, 108]], "entity_1_idx_in_text_with_entity_marker": [99, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[110, 122]], "entity_2_idx_in_text_with_entity_marker": [123, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p19", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[95, 108]], "entity_2_idx_in_text_with_entity_marker": [108, 121], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p20", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[110, 122]], "entity_2_idx_in_text_with_entity_marker": [123, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d811.s0_BioInfer.d811.s0.p0", "text": "We have established an MSH3-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type MSH6 and MSH2 genes, to HHUA cells.", "text_with_entity_marker": "We have established an [E1]MSH3[/E1]-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type MSH6 and [E2]MSH2[/E2] genes, to HHUA cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d811.s0_BioInfer.d811.s0.p1", "text": "We have established an MSH3-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type MSH6 and MSH2 genes, to HHUA cells.", "text_with_entity_marker": "We have established an MSH3-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type [E1]MSH6[/E1] and [E2]MSH2[/E2] genes, to HHUA cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d811.s0_BioInfer.d811.s0.p2", "text": "We have established an MSH3-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type MSH6 and MSH2 genes, to HHUA cells.", "text_with_entity_marker": "We have established an [E1]MSH3[/E1]-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type [E2]MSH6[/E2] and MSH2 genes, to HHUA cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[118, 122]], "entity_2_idx_in_text_with_entity_marker": [131, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d584.s0_BioInfer.d584.s0.p0", "text": "The myosin heavy chain (MHC) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.", "text_with_entity_marker": "The [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[4, 22]], "entity_1_idx_in_text_with_entity_marker": [8, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[24, 27]], "entity_2_idx_in_text_with_entity_marker": [37, 40], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d584.s0_BioInfer.d584.s0.p1", "text": "The myosin heavy chain (MHC) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.", "text_with_entity_marker": "The [E1]myosin heavy chain[/E1] (MHC) contains the [E2]actin[/E2]- and ATP-binding sites and represents the molecular motor of muscle contraction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain", "entity_1_idx": [[4, 22]], "entity_1_idx_in_text_with_entity_marker": [8, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d584.s0_BioInfer.d584.s0.p2", "text": "The myosin heavy chain (MHC) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.", "text_with_entity_marker": "The myosin heavy chain ([E1]MHC[/E1]) contains the [E2]actin[/E2]- and ATP-binding sites and represents the molecular motor of muscle contraction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MHC", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p30", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p31", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p32", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p33", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, [E1]matrix protein[/E1] (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix protein", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p34", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p35", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p36", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p37", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p38", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), [E1]fusion protein[/E1] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p39", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), [E2]small hydrophobic[/E2] (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "small hydrophobic", "entity_2_idx": [[142, 159], [165, 172]], "entity_2_idx_in_text_with_entity_marker": [155, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d6.s0_BioInfer.d6.s0.p0", "text": "Acanthamoeba profilin affects the mechanical properties of nonfilamentous actin.", "text_with_entity_marker": "Acanthamoeba [E1]profilin[/E1] affects the mechanical properties of nonfilamentous [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d6.s1_BioInfer.d6.s1.p0", "text": "In contrast, profilin had little effect on the rigidity and viscosity of actin filaments.", "text_with_entity_marker": "In contrast, [E1]profilin[/E1] had little effect on the rigidity and viscosity of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d6.s2_BioInfer.d6.s2.p0", "text": "We speculate that nonfilamentous actin and profilin, both of which form shear-sensitive structures, can be modeled as flocculant materials.", "text_with_entity_marker": "We speculate that nonfilamentous [E1]actin[/E1] and [E2]profilin[/E2], both of which form shear-sensitive structures, can be modeled as flocculant materials.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[43, 51]], "entity_2_idx_in_text_with_entity_marker": [56, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p0", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that [E1]LIMK2[/E1] functions downstream of the Rho-[E2]ROCK[/E2] signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ROCK", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p1", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that LIMK2 functions downstream of the Rho-[E1]ROCK[/E1] signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating [E2]cofilin/ADF[/E2] proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ROCK", "entity_1_idx": [[65, 69]], "entity_1_idx_in_text_with_entity_marker": [69, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin/ADF", "entity_2_idx": [[187, 198]], "entity_2_idx_in_text_with_entity_marker": [200, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p2", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that LIMK2 functions downstream of the Rho-[E1]ROCK[/E1] signalling pathway and plays a role in reorganization of [E2]actin[/E2] filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ROCK", "entity_1_idx": [[65, 69]], "entity_1_idx_in_text_with_entity_marker": [69, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[127, 132]], "entity_2_idx_in_text_with_entity_marker": [140, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p3", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that LIMK2 functions downstream of the [E1]Rho[/E1]-[E2]ROCK[/E2] signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ROCK", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p4", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that [E1]LIMK2[/E1] functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating [E2]cofilin/ADF[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin/ADF", "entity_2_idx": [[187, 198]], "entity_2_idx_in_text_with_entity_marker": [200, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p5", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that [E1]LIMK2[/E1] functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of [E2]actin[/E2] filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[127, 132]], "entity_2_idx_in_text_with_entity_marker": [140, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p6", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that [E1]LIMK2[/E1] functions downstream of the [E2]Rho[/E2]-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[61, 64]], "entity_2_idx_in_text_with_entity_marker": [74, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p7", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of [E1]actin[/E1] filaments and membrane structures, by phosphorylating [E2]cofilin/ADF[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[127, 132]], "entity_1_idx_in_text_with_entity_marker": [131, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin/ADF", "entity_2_idx": [[187, 198]], "entity_2_idx_in_text_with_entity_marker": [200, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p8", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that LIMK2 functions downstream of the [E1]Rho[/E1]-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating [E2]cofilin/ADF[/E2] proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin/ADF", "entity_2_idx": [[187, 198]], "entity_2_idx_in_text_with_entity_marker": [200, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d713.s0_BioInfer.d713.s0.p9", "text": "These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "text_with_entity_marker": "These results suggest that LIMK2 functions downstream of the [E1]Rho[/E1]-ROCK signalling pathway and plays a role in reorganization of [E2]actin[/E2] filaments and membrane structures, by phosphorylating cofilin/ADF proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[127, 132]], "entity_2_idx_in_text_with_entity_marker": [140, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p20", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), H, [E2]nucleocapsid[/E2] (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[155, 167], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [168, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p21", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein ([E1]P[/E1]), H, nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[148, 149]], "entity_1_idx_in_text_with_entity_marker": [152, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p22", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein ([E1]P[/E1]), [E2]H[/E2], nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[148, 149]], "entity_1_idx_in_text_with_entity_marker": [152, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[152, 153], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [165, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p23", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein ([E2]P[/E2]), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[148, 149]], "entity_2_idx_in_text_with_entity_marker": [161, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p24", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein ([E1]P[/E1]), H, nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[148, 149]], "entity_1_idx_in_text_with_entity_marker": [152, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p25", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] ([E2]P[/E2]), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[148, 149]], "entity_2_idx_in_text_with_entity_marker": [161, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p26", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), [E1]H[/E1], nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[152, 153], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [156, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p27", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein (P), H, nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p28", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid ([E1]N[/E1]) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[169, 170]], "entity_1_idx_in_text_with_entity_marker": [173, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p29", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), H, nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d130.s0_BioInfer.d130.s0.p0", "text": "CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity.", "text_with_entity_marker": "[E1]CD26[/E1] is a T cell activation antigen known to bind [E2]adenosine deaminase[/E2] and have dipeptidyl peptidase IV activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[50, 69]], "entity_2_idx_in_text_with_entity_marker": [63, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d130.s0_BioInfer.d130.s0.p1", "text": "CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity.", "text_with_entity_marker": "[E1]CD26[/E1] is a T cell activation antigen known to bind adenosine deaminase and have [E2]dipeptidyl peptidase IV[/E2] activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[79, 102]], "entity_2_idx_in_text_with_entity_marker": [92, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d130.s0_BioInfer.d130.s0.p2", "text": "CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity.", "text_with_entity_marker": "CD26 is a T cell activation antigen known to bind [E1]adenosine deaminase[/E1] and have [E2]dipeptidyl peptidase IV[/E2] activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine deaminase", "entity_1_idx": [[50, 69]], "entity_1_idx_in_text_with_entity_marker": [54, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[79, 102]], "entity_2_idx_in_text_with_entity_marker": [92, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p20", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p21", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p22", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p23", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E1]N[/E1]; 66 kDa), fusion ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[240, 241]], "entity_1_idx_in_text_with_entity_marker": [244, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p24", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p25", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p26", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E2]matrix[/E2] (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[301, 307], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p27", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p28", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p29", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p27", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not CD44s, CD44v5, CD44v6, [E2]CD44v7-8[/E2], and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v7-8", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p0", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for [E2]beta-catenin[/E2], the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[245, 257]], "entity_2_idx_in_text_with_entity_marker": [258, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p1", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and [E1]beta-catenin[/E1] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for [E2]beta-catenin[/E2], the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[245, 257]], "entity_2_idx_in_text_with_entity_marker": [258, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p2", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or [E1]c-erbB2[/E1] expression, except for [E2]beta-catenin[/E2], the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-erbB2", "entity_1_idx": [[214, 221]], "entity_1_idx_in_text_with_entity_marker": [218, 225], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[245, 257]], "entity_2_idx_in_text_with_entity_marker": [258, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p3", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E1]p53[/E1] expression, Ki-67 labeling, or c-erbB2 expression, except for [E2]beta-catenin[/E2], the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[179, 182]], "entity_1_idx_in_text_with_entity_marker": [183, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[245, 257]], "entity_2_idx_in_text_with_entity_marker": [258, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p4", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for [E1]beta-catenin[/E1], the down-regulation of which was associated with [E2]c-erbB2[/E2] down-regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[245, 257]], "entity_1_idx_in_text_with_entity_marker": [249, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[308, 315]], "entity_2_idx_in_text_with_entity_marker": [321, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p5", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, [E1]alpha-catenin[/E1], and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for [E2]beta-catenin[/E2], the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[245, 257]], "entity_2_idx_in_text_with_entity_marker": [258, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p6", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, [E1]Ki-67[/E1] labeling, or c-erbB2 expression, except for [E2]beta-catenin[/E2], the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ki-67", "entity_1_idx": [[195, 200]], "entity_1_idx_in_text_with_entity_marker": [199, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[245, 257]], "entity_2_idx_in_text_with_entity_marker": [258, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p7", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], alpha-catenin, and [E2]beta-catenin[/E2] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[63, 75]], "entity_2_idx_in_text_with_entity_marker": [76, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p8", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or [E2]c-erbB2[/E2] expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[214, 221]], "entity_2_idx_in_text_with_entity_marker": [227, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p30", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and [E1]RAD1[/E1], RAD2, RAD3, [E2]RAD10[/E2], RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD1", "entity_1_idx": [[134, 138]], "entity_1_idx_in_text_with_entity_marker": [138, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD10", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p31", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, [E1]RAD2[/E1], RAD3, [E2]RAD10[/E2], RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD2", "entity_1_idx": [[140, 144]], "entity_1_idx_in_text_with_entity_marker": [144, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD10", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p32", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, [E1]RAD10[/E1], [E2]RAD14[/E2], and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD10", "entity_1_idx": [[152, 157]], "entity_1_idx_in_text_with_entity_marker": [156, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD14", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p33", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and [E1]RAD1[/E1], [E2]RAD2[/E2], RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD1", "entity_1_idx": [[134, 138]], "entity_1_idx_in_text_with_entity_marker": [138, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD2", "entity_2_idx": [[140, 144]], "entity_2_idx_in_text_with_entity_marker": [153, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p34", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and [E1]RAD1[/E1], RAD2, RAD3, RAD10, [E2]RAD14[/E2], and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD1", "entity_1_idx": [[134, 138]], "entity_1_idx_in_text_with_entity_marker": [138, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD14", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p35", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, [E1]RAD2[/E1], RAD3, RAD10, [E2]RAD14[/E2], and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD2", "entity_1_idx": [[140, 144]], "entity_1_idx_in_text_with_entity_marker": [144, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD14", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p0", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three actin-associated proteins, [E1]actin-binding protein[/E1], [E2]gelsolin[/E2], and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[33, 54]], "entity_1_idx_in_text_with_entity_marker": [37, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[56, 64]], "entity_2_idx_in_text_with_entity_marker": [69, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p1", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three [E1]actin[/E1]-associated proteins, actin-binding protein, [E2]gelsolin[/E2], and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[56, 64]], "entity_2_idx_in_text_with_entity_marker": [69, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p2", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three actin-associated proteins, actin-binding protein, [E1]gelsolin[/E1], and profilin, influence gelation, solation, and polymerization, respectively, of [E2]actin[/E2] in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[56, 64]], "entity_1_idx_in_text_with_entity_marker": [60, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p3", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three actin-associated proteins, actin-binding protein, [E1]gelsolin[/E1], and [E2]profilin[/E2], influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[56, 64]], "entity_1_idx_in_text_with_entity_marker": [60, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[70, 78]], "entity_2_idx_in_text_with_entity_marker": [83, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p4", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three [E1]actin[/E1]-associated proteins, [E2]actin-binding protein[/E2], gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[33, 54]], "entity_2_idx_in_text_with_entity_marker": [46, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p5", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three actin-associated proteins, [E1]actin-binding protein[/E1], gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of [E2]actin[/E2] in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[33, 54]], "entity_1_idx_in_text_with_entity_marker": [37, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p6", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three actin-associated proteins, [E1]actin-binding protein[/E1], gelsolin, and [E2]profilin[/E2], influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[33, 54]], "entity_1_idx_in_text_with_entity_marker": [37, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[70, 78]], "entity_2_idx_in_text_with_entity_marker": [83, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p7", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three [E1]actin[/E1]-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of [E2]actin[/E2] in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p8", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three [E1]actin[/E1]-associated proteins, actin-binding protein, gelsolin, and [E2]profilin[/E2], influence gelation, solation, and polymerization, respectively, of actin in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[70, 78]], "entity_2_idx_in_text_with_entity_marker": [83, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d749.s0_BioInfer.d749.s0.p9", "text": "Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.", "text_with_entity_marker": "Three actin-associated proteins, actin-binding protein, gelsolin, and [E1]profilin[/E1], influence gelation, solation, and polymerization, respectively, of [E2]actin[/E2] in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[70, 78]], "entity_1_idx_in_text_with_entity_marker": [74, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p80", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E1]MAP kinase[/E1]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/[E2]WSC1[/E2]/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAP kinase", "entity_1_idx": [[120, 130]], "entity_1_idx_in_text_with_entity_marker": [124, 134], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "WSC1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p81", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E1]RHO2[/E1], HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RHO2", "entity_1_idx": [[264, 268]], "entity_1_idx_in_text_with_entity_marker": [268, 272], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p82", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p83", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E1]ROM2[/E1], RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ROM2", "entity_1_idx": [[258, 262]], "entity_1_idx_in_text_with_entity_marker": [262, 266], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p84", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E1]MID2[/E1] also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MID2", "entity_1_idx": [[290, 294]], "entity_1_idx_in_text_with_entity_marker": [294, 298], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p85", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E1]glc7-10[/E1] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glc7-10", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p86", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked [E1]PKC1[/E1] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p87", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E1]SLG1[/E1] and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SLG1", "entity_1_idx": [[281, 285]], "entity_1_idx_in_text_with_entity_marker": [285, 289], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p88", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p89", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d487.s0_BioInfer.d487.s0.p0", "text": "Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of fimbrin, or it could regulate the interaction of fimbrin with other proteins.", "text_with_entity_marker": "Phosphorylation of the headpiece domain could regulate the [E1]actin[/E1] binding and bundling properties of [E2]fimbrin[/E2], or it could regulate the interaction of fimbrin with other proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[100, 107]], "entity_2_idx_in_text_with_entity_marker": [113, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d487.s0_BioInfer.d487.s0.p1", "text": "Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of fimbrin, or it could regulate the interaction of fimbrin with other proteins.", "text_with_entity_marker": "Phosphorylation of the headpiece domain could regulate the [E1]actin[/E1] binding and bundling properties of fimbrin, or it could regulate the interaction of [E2]fimbrin[/E2] with other proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d487.s0_BioInfer.d487.s0.p2", "text": "Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of fimbrin, or it could regulate the interaction of fimbrin with other proteins.", "text_with_entity_marker": "Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of [E1]fimbrin[/E1], or it could regulate the interaction of [E2]fimbrin[/E2] with other proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[100, 107]], "entity_1_idx_in_text_with_entity_marker": [104, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[149, 156]], "entity_2_idx_in_text_with_entity_marker": [162, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p0", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or [E1]E-cadherin[/E1] immunoprecipitates from BMMC lysate revealed that alpha-catenin, [E2]beta-catenin[/E2], and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[104, 116]], "entity_2_idx_in_text_with_entity_marker": [117, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p1", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or [E1]E-cadherin[/E1] immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and [E2]catenins[/E2] form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "catenins", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p2", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or [E1]E-cadherin[/E1] immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that [E2]E-cadherin[/E2] and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[171, 181]], "entity_2_idx_in_text_with_entity_marker": [184, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p3", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of [E1]beta-catenin[/E1] or [E2]E-cadherin[/E2] immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[28, 38]], "entity_2_idx_in_text_with_entity_marker": [41, 51], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p4", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or [E1]E-cadherin[/E1] immunoprecipitates from BMMC lysate revealed that [E2]alpha-catenin[/E2], beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[89, 102]], "entity_2_idx_in_text_with_entity_marker": [102, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p5", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or [E1]E-cadherin[/E1] immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and [E2]E-cadherin[/E2] were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p6", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, [E1]beta-catenin[/E1], and E-cadherin were co-precipitated, suggesting that E-cadherin and [E2]catenins[/E2] form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[104, 116]], "entity_1_idx_in_text_with_entity_marker": [108, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenins", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p7", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, [E1]beta-catenin[/E1], and E-cadherin were co-precipitated, suggesting that [E2]E-cadherin[/E2] and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[104, 116]], "entity_1_idx_in_text_with_entity_marker": [108, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[171, 181]], "entity_2_idx_in_text_with_entity_marker": [184, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p8", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of [E1]beta-catenin[/E1] or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, [E2]beta-catenin[/E2], and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[104, 116]], "entity_2_idx_in_text_with_entity_marker": [117, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p9", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[89, 102]], "entity_1_idx_in_text_with_entity_marker": [93, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[104, 116]], "entity_2_idx_in_text_with_entity_marker": [117, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p10", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, [E1]beta-catenin[/E1], and [E2]E-cadherin[/E2] were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[104, 116]], "entity_1_idx_in_text_with_entity_marker": [108, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p11", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that [E1]E-cadherin[/E1] and [E2]catenins[/E2] form a complex in mast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[171, 181]], "entity_1_idx_in_text_with_entity_marker": [175, 185], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenins", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p12", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of [E1]beta-catenin[/E1] or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and [E2]catenins[/E2] form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "catenins", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p13", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that [E1]alpha-catenin[/E1], beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and [E2]catenins[/E2] form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[89, 102]], "entity_1_idx_in_text_with_entity_marker": [93, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenins", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p14", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and [E1]E-cadherin[/E1] were co-precipitated, suggesting that E-cadherin and [E2]catenins[/E2] form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[122, 132]], "entity_1_idx_in_text_with_entity_marker": [126, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenins", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p15", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of [E1]beta-catenin[/E1] or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that [E2]E-cadherin[/E2] and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[171, 181]], "entity_2_idx_in_text_with_entity_marker": [184, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p16", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that [E1]alpha-catenin[/E1], beta-catenin, and E-cadherin were co-precipitated, suggesting that [E2]E-cadherin[/E2] and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[89, 102]], "entity_1_idx_in_text_with_entity_marker": [93, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[171, 181]], "entity_2_idx_in_text_with_entity_marker": [184, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p17", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and [E1]E-cadherin[/E1] were co-precipitated, suggesting that [E2]E-cadherin[/E2] and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[122, 132]], "entity_1_idx_in_text_with_entity_marker": [126, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[171, 181]], "entity_2_idx_in_text_with_entity_marker": [184, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p18", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of [E1]beta-catenin[/E1] or E-cadherin immunoprecipitates from BMMC lysate revealed that [E2]alpha-catenin[/E2], beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[89, 102]], "entity_2_idx_in_text_with_entity_marker": [102, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p19", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of [E1]beta-catenin[/E1] or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and [E2]E-cadherin[/E2] were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p20", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that [E1]alpha-catenin[/E1], beta-catenin, and [E2]E-cadherin[/E2] were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[89, 102]], "entity_1_idx_in_text_with_entity_marker": [93, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p0", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin (alpha-cat) and [E2]beta-catenin[/E2] (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[196, 208]], "entity_2_idx_in_text_with_entity_marker": [209, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p1", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] (E-cad), [E2]alpha-catenin[/E2] (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[166, 179]], "entity_2_idx_in_text_with_entity_marker": [179, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p2", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin (alpha-cat) and beta-catenin ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p3", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin ([E2]alpha-cat[/E2]) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-cat", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p4", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] ([E2]E-cad[/E2]), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cad", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p5", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), [E1]alpha-catenin[/E1] (alpha-cat) and [E2]beta-catenin[/E2] (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[166, 179]], "entity_1_idx_in_text_with_entity_marker": [170, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[196, 208]], "entity_2_idx_in_text_with_entity_marker": [209, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p6", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and [E1]beta-catenin[/E1] ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[196, 208]], "entity_1_idx_in_text_with_entity_marker": [200, 212], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p7", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin ([E1]alpha-cat[/E1]) and [E2]beta-catenin[/E2] (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-cat", "entity_1_idx": [[181, 190]], "entity_1_idx_in_text_with_entity_marker": [185, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[196, 208]], "entity_2_idx_in_text_with_entity_marker": [209, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p8", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin (alpha-cat) and [E2]beta-catenin[/E2] (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[196, 208]], "entity_2_idx_in_text_with_entity_marker": [209, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p9", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), [E1]alpha-catenin[/E1] (alpha-cat) and beta-catenin ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[166, 179]], "entity_1_idx_in_text_with_entity_marker": [170, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p10", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), [E1]alpha-catenin[/E1] ([E2]alpha-cat[/E2]) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[166, 179]], "entity_1_idx_in_text_with_entity_marker": [170, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-cat", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p11", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin ([E1]E-cad[/E1]), [E2]alpha-catenin[/E2] (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[166, 179]], "entity_2_idx_in_text_with_entity_marker": [179, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p12", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin ([E1]alpha-cat[/E1]) and beta-catenin ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-cat", "entity_1_idx": [[181, 190]], "entity_1_idx_in_text_with_entity_marker": [185, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p13", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin (alpha-cat) and beta-catenin ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p14", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin ([E2]alpha-cat[/E2]) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-cat", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d552.s0_BioInfer.d552.s0.p0", "text": "Studies on cultured cells have suggested that both alpha-catenin and plakoglobin are important for the adhesive function of cadherins.", "text_with_entity_marker": "Studies on cultured cells have suggested that both [E1]alpha-catenin[/E1] and plakoglobin are important for the adhesive function of [E2]cadherins[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[51, 64]], "entity_1_idx_in_text_with_entity_marker": [55, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[124, 133]], "entity_2_idx_in_text_with_entity_marker": [137, 146], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d552.s0_BioInfer.d552.s0.p1", "text": "Studies on cultured cells have suggested that both alpha-catenin and plakoglobin are important for the adhesive function of cadherins.", "text_with_entity_marker": "Studies on cultured cells have suggested that both alpha-catenin and [E1]plakoglobin[/E1] are important for the adhesive function of [E2]cadherins[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[69, 80]], "entity_1_idx_in_text_with_entity_marker": [73, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[124, 133]], "entity_2_idx_in_text_with_entity_marker": [137, 146], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d552.s0_BioInfer.d552.s0.p2", "text": "Studies on cultured cells have suggested that both alpha-catenin and plakoglobin are important for the adhesive function of cadherins.", "text_with_entity_marker": "Studies on cultured cells have suggested that both [E1]alpha-catenin[/E1] and [E2]plakoglobin[/E2] are important for the adhesive function of cadherins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[51, 64]], "entity_1_idx_in_text_with_entity_marker": [55, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[69, 80]], "entity_2_idx_in_text_with_entity_marker": [82, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d338.s0_BioInfer.d338.s0.p0", "text": "Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of cofilin.", "text_with_entity_marker": "Inhibition of [E1]actin[/E1] polymerization by a synthetic dodecapeptide patterned on the sequence around the [E2]actin[/E2]-binding site of cofilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d338.s0_BioInfer.d338.s0.p1", "text": "Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of cofilin.", "text_with_entity_marker": "Inhibition of [E1]actin[/E1] polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[123, 130]], "entity_2_idx_in_text_with_entity_marker": [136, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d338.s0_BioInfer.d338.s0.p2", "text": "Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of cofilin.", "text_with_entity_marker": "Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the [E1]actin[/E1]-binding site of [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[123, 130]], "entity_2_idx_in_text_with_entity_marker": [136, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s0_BioInfer.d59.s0.p0", "text": "Analysis of this product by peptide mapping (Sutoh (1982) Biochemistry 21, 3654-3661) showed that cofilin was cross-linked with the N-terminal segment of actin containing residues 1-12.", "text_with_entity_marker": "Analysis of this product by peptide mapping (Sutoh (1982) Biochemistry 21, 3654-3661) showed that [E1]cofilin[/E1] was cross-linked with the N-terminal segment of [E2]actin[/E2] containing residues 1-12.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[154, 159]], "entity_2_idx_in_text_with_entity_marker": [167, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s1_BioInfer.d59.s1.p0", "text": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "text_with_entity_marker": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the [E1]cofilin[/E1]-binding site in the [E2]actin[/E2] sequence.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[120, 127]], "entity_1_idx_in_text_with_entity_marker": [124, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s1_BioInfer.d59.s1.p1", "text": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "text_with_entity_marker": "Purification of cofilin, a 21,000 molecular weight [E1]actin-binding protein[/E1], from porcine kidney and identification of the cofilin-binding site in the [E2]actin[/E2] sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[51, 72]], "entity_1_idx_in_text_with_entity_marker": [55, 76], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s1_BioInfer.d59.s1.p2", "text": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "text_with_entity_marker": "Purification of [E1]cofilin[/E1], a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the [E2]actin[/E2] sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s1_BioInfer.d59.s1.p3", "text": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "text_with_entity_marker": "Purification of cofilin, a 21,000 molecular weight [E1]actin-binding protein[/E1], from porcine kidney and identification of the [E2]cofilin[/E2]-binding site in the actin sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[51, 72]], "entity_1_idx_in_text_with_entity_marker": [55, 76], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[120, 127]], "entity_2_idx_in_text_with_entity_marker": [133, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s1_BioInfer.d59.s1.p4", "text": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "text_with_entity_marker": "Purification of [E1]cofilin[/E1], a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the [E2]cofilin[/E2]-binding site in the actin sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[120, 127]], "entity_2_idx_in_text_with_entity_marker": [133, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d59.s1_BioInfer.d59.s1.p5", "text": "Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "text_with_entity_marker": "Purification of [E1]cofilin[/E1], a 21,000 molecular weight [E2]actin-binding protein[/E2], from porcine kidney and identification of the cofilin-binding site in the actin sequence.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[51, 72]], "entity_2_idx_in_text_with_entity_marker": [64, 85], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d466.s0_BioInfer.d466.s0.p0", "text": "On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.", "text_with_entity_marker": "On the internal (cytoplasmic) side of focal contacts, several proteins, including [E1]talin[/E1] and [E2]vinculin[/E2], mediate interactions with the actin filament bundles of the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[92, 100]], "entity_2_idx_in_text_with_entity_marker": [105, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d466.s0_BioInfer.d466.s0.p1", "text": "On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.", "text_with_entity_marker": "On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and [E1]vinculin[/E1], mediate interactions with the [E2]actin[/E2] filament bundles of the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[92, 100]], "entity_1_idx_in_text_with_entity_marker": [96, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[132, 137]], "entity_2_idx_in_text_with_entity_marker": [145, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d466.s0_BioInfer.d466.s0.p2", "text": "On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.", "text_with_entity_marker": "On the internal (cytoplasmic) side of focal contacts, several proteins, including [E1]talin[/E1] and vinculin, mediate interactions with the [E2]actin[/E2] filament bundles of the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[132, 137]], "entity_2_idx_in_text_with_entity_marker": [145, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s0_BioInfer.d140.s0.p0", "text": "Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.", "text_with_entity_marker": "Characterization of the interactions of [E1]alpha-catenin[/E1] with [E2]alpha-actinin[/E2] and beta-catenin/plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[40, 53]], "entity_1_idx_in_text_with_entity_marker": [44, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[59, 72]], "entity_2_idx_in_text_with_entity_marker": [72, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s0_BioInfer.d140.s0.p1", "text": "Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.", "text_with_entity_marker": "Characterization of the interactions of alpha-catenin with [E1]alpha-actinin[/E1] and beta-catenin/[E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-actinin", "entity_1_idx": [[59, 72]], "entity_1_idx_in_text_with_entity_marker": [63, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[90, 101]], "entity_2_idx_in_text_with_entity_marker": [103, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s0_BioInfer.d140.s0.p2", "text": "Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.", "text_with_entity_marker": "Characterization of the interactions of alpha-catenin with [E1]alpha-actinin[/E1] and [E2]beta-catenin[/E2]/plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-actinin", "entity_1_idx": [[59, 72]], "entity_1_idx_in_text_with_entity_marker": [63, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[77, 89]], "entity_2_idx_in_text_with_entity_marker": [90, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s0_BioInfer.d140.s0.p3", "text": "Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.", "text_with_entity_marker": "Characterization of the interactions of [E1]alpha-catenin[/E1] with alpha-actinin and beta-catenin/[E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[40, 53]], "entity_1_idx_in_text_with_entity_marker": [44, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[90, 101]], "entity_2_idx_in_text_with_entity_marker": [103, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s0_BioInfer.d140.s0.p4", "text": "Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.", "text_with_entity_marker": "Characterization of the interactions of [E1]alpha-catenin[/E1] with alpha-actinin and [E2]beta-catenin[/E2]/plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[40, 53]], "entity_1_idx_in_text_with_entity_marker": [44, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[77, 89]], "entity_2_idx_in_text_with_entity_marker": [90, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s0_BioInfer.d140.s0.p5", "text": "Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.", "text_with_entity_marker": "Characterization of the interactions of alpha-catenin with alpha-actinin and [E1]beta-catenin[/E1]/[E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[77, 89]], "entity_1_idx_in_text_with_entity_marker": [81, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[90, 101]], "entity_2_idx_in_text_with_entity_marker": [103, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s1_BioInfer.d140.s1.p0", "text": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.", "text_with_entity_marker": "In this study we have used the yeast two-hybrid system to map the domains on [E1]alpha-catenin[/E1] that allow it to associate with beta-catenin/[E2]plakoglobin[/E2] and with alpha-actinin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[77, 90]], "entity_1_idx_in_text_with_entity_marker": [81, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s1_BioInfer.d140.s1.p1", "text": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.", "text_with_entity_marker": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with [E1]beta-catenin[/E1]/[E2]plakoglobin[/E2] and with alpha-actinin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[123, 135]], "entity_1_idx_in_text_with_entity_marker": [127, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s1_BioInfer.d140.s1.p2", "text": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.", "text_with_entity_marker": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/[E1]plakoglobin[/E1] and with [E2]alpha-actinin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[136, 147]], "entity_1_idx_in_text_with_entity_marker": [140, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[157, 170]], "entity_2_idx_in_text_with_entity_marker": [170, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s1_BioInfer.d140.s1.p3", "text": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.", "text_with_entity_marker": "In this study we have used the yeast two-hybrid system to map the domains on [E1]alpha-catenin[/E1] that allow it to associate with [E2]beta-catenin[/E2]/plakoglobin and with alpha-actinin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[77, 90]], "entity_1_idx_in_text_with_entity_marker": [81, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[123, 135]], "entity_2_idx_in_text_with_entity_marker": [136, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p28", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/[E1]catenin[/E1] complex to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "catenin", "entity_1_idx": [[150, 157]], "entity_1_idx_in_text_with_entity_marker": [154, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p29", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to [E1]beta-catenin[/E1]/plakoglobin and serves to link the cadherin/[E2]catenin[/E2] complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[93, 105]], "entity_1_idx_in_text_with_entity_marker": [97, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p30", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the cadherin; [E1]alpha-catenin[/E1] binds to beta-catenin/[E2]plakoglobin[/E2] and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[70, 83]], "entity_1_idx_in_text_with_entity_marker": [74, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[106, 117]], "entity_2_idx_in_text_with_entity_marker": [119, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p31", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the cadherin; [E1]alpha-catenin[/E1] binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[70, 83]], "entity_1_idx_in_text_with_entity_marker": [74, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p32", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the cadherin; [E1]alpha-catenin[/E1] binds to [E2]beta-catenin[/E2]/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[70, 83]], "entity_1_idx_in_text_with_entity_marker": [74, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[93, 105]], "entity_2_idx_in_text_with_entity_marker": [106, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p33", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/[E1]plakoglobin[/E1] and serves to link the cadherin/catenin complex to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[106, 117]], "entity_1_idx_in_text_with_entity_marker": [110, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p34", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to [E1]beta-catenin[/E1]/[E2]plakoglobin[/E2] and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[93, 105]], "entity_1_idx_in_text_with_entity_marker": [97, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[106, 117]], "entity_2_idx_in_text_with_entity_marker": [119, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p35", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to [E1]beta-catenin[/E1]/plakoglobin and serves to link the cadherin/catenin complex to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[93, 105]], "entity_1_idx_in_text_with_entity_marker": [97, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p0", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid [E1]myosin[/E1]: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten [E2]myosin heavy chain[/E2], and Cys-374 of actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[83, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[178, 196]], "entity_2_idx_in_text_with_entity_marker": [191, 209], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p1", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten [E1]myosin heavy chain[/E1], and Cys-374 of [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[178, 196]], "entity_1_idx_in_text_with_entity_marker": [182, 200], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[213, 218]], "entity_2_idx_in_text_with_entity_marker": [226, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p2", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria [E1]regulatory light chain[/E1], SH-1 on the Aequipecten [E2]myosin heavy chain[/E2], and Cys-374 of actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "regulatory light chain", "entity_1_idx": [[130, 152]], "entity_1_idx_in_text_with_entity_marker": [134, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[178, 196]], "entity_2_idx_in_text_with_entity_marker": [191, 209], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p3", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid [E1]myosin[/E1]: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[83, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[213, 218]], "entity_2_idx_in_text_with_entity_marker": [226, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p4", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid [E1]myosin[/E1]: those between Cys-55 on the Mercenaria [E2]regulatory light chain[/E2], SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[83, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "regulatory light chain", "entity_2_idx": [[130, 152]], "entity_2_idx_in_text_with_entity_marker": [143, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d521.s0_BioInfer.d521.s0.p5", "text": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.", "text_with_entity_marker": "Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria [E1]regulatory light chain[/E1], SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "regulatory light chain", "entity_1_idx": [[130, 152]], "entity_1_idx_in_text_with_entity_marker": [134, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[213, 218]], "entity_2_idx_in_text_with_entity_marker": [226, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d655.s0_BioInfer.d655.s0.p0", "text": "The ordered assembly of the talin homologue together with actin and a series of other proteins is considered to play a key role in chemotactic orientation.", "text_with_entity_marker": "The ordered assembly of the [E1]talin[/E1] homologue together with [E2]actin[/E2] and a series of other proteins is considered to play a key role in chemotactic orientation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s0_BioInfer.d198.s0.p0", "text": "Experiments performed using extracts from doubly infected cells indicated that UL8 could interact separately with both the UL5 and UL52 proteins.", "text_with_entity_marker": "Experiments performed using extracts from doubly infected cells indicated that UL8 could interact separately with both the [E1]UL5[/E1] and [E2]UL52[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s0_BioInfer.d198.s0.p1", "text": "Experiments performed using extracts from doubly infected cells indicated that UL8 could interact separately with both the UL5 and UL52 proteins.", "text_with_entity_marker": "Experiments performed using extracts from doubly infected cells indicated that [E1]UL8[/E1] could interact separately with both the UL5 and [E2]UL52[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s0_BioInfer.d198.s0.p2", "text": "Experiments performed using extracts from doubly infected cells indicated that UL8 could interact separately with both the UL5 and UL52 proteins.", "text_with_entity_marker": "Experiments performed using extracts from doubly infected cells indicated that [E1]UL8[/E1] could interact separately with both the [E2]UL5[/E2] and UL52 proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p0", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the [E1]UL5[/E1], UL8 and [E2]UL52[/E2] polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[241, 245]], "entity_2_idx_in_text_with_entity_marker": [254, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p1", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the [E1]UL5[/E1], [E2]UL8[/E2] and UL52 polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p2", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "MAb 0811 was shown to recognize the [E1]UL8[/E1] protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the [E2]UL5[/E2], UL8 and UL52 polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[228, 231]], "entity_2_idx_in_text_with_entity_marker": [241, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p3", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "[E1]MAb 0811[/E1] was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the [E2]UL5[/E2], UL8 and UL52 polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAb 0811", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[228, 231]], "entity_2_idx_in_text_with_entity_marker": [241, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p4", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, [E1]UL8[/E1] and [E2]UL52[/E2] polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[241, 245]], "entity_2_idx_in_text_with_entity_marker": [254, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p5", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "MAb 0811 was shown to recognize the [E1]UL8[/E1] protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and [E2]UL52[/E2] polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[241, 245]], "entity_2_idx_in_text_with_entity_marker": [254, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p6", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "[E1]MAb 0811[/E1] was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and [E2]UL52[/E2] polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAb 0811", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[241, 245]], "entity_2_idx_in_text_with_entity_marker": [254, 258], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p7", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "MAb 0811 was shown to recognize the [E1]UL8[/E1] protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, [E2]UL8[/E2] and UL52 polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p8", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "[E1]MAb 0811[/E1] was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, [E2]UL8[/E2] and UL52 polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAb 0811", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d198.s1_BioInfer.d198.s1.p9", "text": "MAb 0811 was shown to recognize the UL8 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "text_with_entity_marker": "[E1]MAb 0811[/E1] was shown to recognize the [E2]UL8[/E2] protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the UL5, UL8 and UL52 polypeptides.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MAb 0811", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[36, 39]], "entity_2_idx_in_text_with_entity_marker": [49, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p0", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two [E2]NP[/E2] binding sites on P is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[42, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[121, 123]], "entity_2_idx_in_text_with_entity_marker": [134, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p1", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein ([E2]P[/E2]) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NP", "entity_1_idx": [[42, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[66, 67]], "entity_2_idx_in_text_with_entity_marker": [79, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p2", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein ([E1]NP[/E1]) and [E2]phosphoprotein[/E2] (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NP", "entity_1_idx": [[42, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[50, 64]], "entity_2_idx_in_text_with_entity_marker": [63, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p3", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[20, 40]], "entity_1_idx_in_text_with_entity_marker": [24, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[42, 44]], "entity_2_idx_in_text_with_entity_marker": [55, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p4", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on [E2]P[/E2] is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[42, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[141, 142]], "entity_2_idx_in_text_with_entity_marker": [154, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p5", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) of human parainfluenza virus type 2: one of the two [E2]NP[/E2] binding sites on P is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[66, 67]], "entity_1_idx_in_text_with_entity_marker": [70, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[121, 123]], "entity_2_idx_in_text_with_entity_marker": [134, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p6", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) of human parainfluenza virus type 2: one of the two [E2]NP[/E2] binding sites on P is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[50, 64]], "entity_1_idx_in_text_with_entity_marker": [54, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[121, 123]], "entity_2_idx_in_text_with_entity_marker": [134, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p7", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two [E2]NP[/E2] binding sites on P is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[20, 40]], "entity_1_idx_in_text_with_entity_marker": [24, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[121, 123]], "entity_2_idx_in_text_with_entity_marker": [134, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p8", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two [E1]NP[/E1] binding sites on [E2]P[/E2] is essential for granule formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NP", "entity_1_idx": [[121, 123]], "entity_1_idx_in_text_with_entity_marker": [125, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[141, 142]], "entity_2_idx_in_text_with_entity_marker": [154, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p9", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] ([E2]P[/E2]) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[50, 64]], "entity_1_idx_in_text_with_entity_marker": [54, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[66, 67]], "entity_2_idx_in_text_with_entity_marker": [79, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p10", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein ([E2]P[/E2]) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleocapsid protein", "entity_1_idx": [[20, 40]], "entity_1_idx_in_text_with_entity_marker": [24, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[66, 67]], "entity_2_idx_in_text_with_entity_marker": [79, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p11", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) of human parainfluenza virus type 2: one of the two NP binding sites on [E2]P[/E2] is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[66, 67]], "entity_1_idx_in_text_with_entity_marker": [70, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[141, 142]], "entity_2_idx_in_text_with_entity_marker": [154, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p12", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between [E1]nucleocapsid protein[/E1] (NP) and [E2]phosphoprotein[/E2] (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleocapsid protein", "entity_1_idx": [[20, 40]], "entity_1_idx_in_text_with_entity_marker": [24, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[50, 64]], "entity_2_idx_in_text_with_entity_marker": [63, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p13", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) of human parainfluenza virus type 2: one of the two NP binding sites on [E2]P[/E2] is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[50, 64]], "entity_1_idx_in_text_with_entity_marker": [54, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[141, 142]], "entity_2_idx_in_text_with_entity_marker": [154, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d359.s0_BioInfer.d359.s0.p14", "text": "Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.", "text_with_entity_marker": "Interaction between [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on [E2]P[/E2] is essential for granule formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[20, 40]], "entity_1_idx_in_text_with_entity_marker": [24, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[141, 142]], "entity_2_idx_in_text_with_entity_marker": [154, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p110", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] ([E2]PNR[/E2]), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PNR", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p111", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p112", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), histone [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p113", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), [E2]proliferating cell nuclear antigen[/E2] (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[150, 184]], "entity_2_idx_in_text_with_entity_marker": [163, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p114", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p115", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), [E2]dihydrofolate reductase[/E2] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dihydrofolate reductase", "entity_2_idx": [[86, 109]], "entity_2_idx_in_text_with_entity_marker": [99, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p116", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), [E2]ribonucleotide reductase[/E2] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ribonucleotide reductase", "entity_2_idx": [[118, 142]], "entity_2_idx_in_text_with_entity_marker": [131, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p117", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p118", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p119", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E2]proliferating cell nuclear antigen[/E2] (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[150, 184]], "entity_2_idx_in_text_with_entity_marker": [163, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p10", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and [E1]HMR-1[/E1] proteins are related to the [E2]cell adhesion proteins[/E2] alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMR-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cell adhesion proteins", "entity_2_idx": [[83, 105]], "entity_2_idx_in_text_with_entity_marker": [96, 118], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p11", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the [E1]cell adhesion proteins[/E1] alpha-catenin, beta-catenin/[E2]Armadillo[/E2], and classical cadherin, respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cell adhesion proteins", "entity_1_idx": [[83, 105]], "entity_1_idx_in_text_with_entity_marker": [87, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Armadillo", "entity_2_idx": [[134, 143]], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p12", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted [E1]HMP-1[/E1], HMP-2, and HMR-1 proteins are related to the [E2]cell adhesion proteins[/E2] alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cell adhesion proteins", "entity_2_idx": [[83, 105]], "entity_2_idx_in_text_with_entity_marker": [96, 118], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p13", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins [E1]alpha-catenin[/E1], beta-catenin/Armadillo, and [E2]classical cadherin[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[106, 119]], "entity_1_idx_in_text_with_entity_marker": [110, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "classical cadherin", "entity_2_idx": [[149, 167]], "entity_2_idx_in_text_with_entity_marker": [162, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p14", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, [E1]HMP-2[/E1], and HMR-1 proteins are related to the cell adhesion proteins [E2]alpha-catenin[/E2], beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-2", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[106, 119]], "entity_2_idx_in_text_with_entity_marker": [119, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p15", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and [E1]HMR-1[/E1] proteins are related to the cell adhesion proteins [E2]alpha-catenin[/E2], beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMR-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[106, 119]], "entity_2_idx_in_text_with_entity_marker": [119, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p16", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins [E1]alpha-catenin[/E1], beta-catenin/[E2]Armadillo[/E2], and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[106, 119]], "entity_1_idx_in_text_with_entity_marker": [110, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Armadillo", "entity_2_idx": [[134, 143]], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p17", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted [E1]HMP-1[/E1], HMP-2, and HMR-1 proteins are related to the cell adhesion proteins [E2]alpha-catenin[/E2], beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HMP-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[106, 119]], "entity_2_idx_in_text_with_entity_marker": [119, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p18", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, [E1]HMP-2[/E1], and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and [E2]classical cadherin[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-2", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "classical cadherin", "entity_2_idx": [[149, 167]], "entity_2_idx_in_text_with_entity_marker": [162, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p19", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and [E1]HMR-1[/E1] proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and [E2]classical cadherin[/E2], respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HMR-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "classical cadherin", "entity_2_idx": [[149, 167]], "entity_2_idx_in_text_with_entity_marker": [162, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d440.s0_BioInfer.d440.s0.p0", "text": "Most previous studies have focused on profilin itself rather than its complex with actin.", "text_with_entity_marker": "Most previous studies have focused on [E1]profilin[/E1] itself rather than its complex with [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d511.s0_BioInfer.d511.s0.p0", "text": "Redistribution of actin, profilin and phosphatidylinositol-4, 5-bisphosphate in growing and maturing root hairs", "text_with_entity_marker": "Redistribution of [E1]actin[/E1], [E2]profilin[/E2] and phosphatidylinositol-4, 5-bisphosphate in growing and maturing root hairs", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[25, 33]], "entity_2_idx_in_text_with_entity_marker": [38, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p0", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins [E1]tropomyosin[/E1] and [E2]profilin[/E2] also did not exhibit medial GFP-Cdc42p staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[170, 181]], "entity_1_idx_in_text_with_entity_marker": [174, 185], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p1", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and [E1]profilin[/E1] also did not exhibit medial GFP-[E2]Cdc42p[/E2] staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[186, 194]], "entity_1_idx_in_text_with_entity_marker": [190, 198], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdc42p", "entity_2_idx": [[227, 233]], "entity_2_idx_in_text_with_entity_marker": [240, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p2", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the [E1]actin[/E1]-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and [E2]profilin[/E2] also did not exhibit medial GFP-Cdc42p staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p3", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and [E1]profilin[/E1] also did not exhibit medial [E2]GFP[/E2]-Cdc42p staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[186, 194]], "entity_1_idx_in_text_with_entity_marker": [190, 198], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GFP", "entity_2_idx": [[223, 226]], "entity_2_idx_in_text_with_entity_marker": [236, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p4", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the [E1]actin-binding proteins[/E1] tropomyosin and [E2]profilin[/E2] also did not exhibit medial GFP-Cdc42p staining.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[147, 169]], "entity_1_idx_in_text_with_entity_marker": [151, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p5", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins [E1]tropomyosin[/E1] and profilin also did not exhibit medial GFP-[E2]Cdc42p[/E2] staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[170, 181]], "entity_1_idx_in_text_with_entity_marker": [174, 185], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdc42p", "entity_2_idx": [[227, 233]], "entity_2_idx_in_text_with_entity_marker": [240, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p6", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the [E1]actin[/E1]-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins [E2]tropomyosin[/E2] and profilin also did not exhibit medial GFP-Cdc42p staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[170, 181]], "entity_2_idx_in_text_with_entity_marker": [183, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p7", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins [E1]tropomyosin[/E1] and profilin also did not exhibit medial [E2]GFP[/E2]-Cdc42p staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[170, 181]], "entity_1_idx_in_text_with_entity_marker": [174, 185], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GFP", "entity_2_idx": [[223, 226]], "entity_2_idx_in_text_with_entity_marker": [236, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p8", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the [E1]actin-binding proteins[/E1] [E2]tropomyosin[/E2] and profilin also did not exhibit medial GFP-Cdc42p staining.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[147, 169]], "entity_1_idx_in_text_with_entity_marker": [151, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "tropomyosin", "entity_2_idx": [[170, 181]], "entity_2_idx_in_text_with_entity_marker": [183, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p9", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the [E1]actin[/E1]-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-[E2]Cdc42p[/E2] staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Cdc42p", "entity_2_idx": [[227, 233]], "entity_2_idx_in_text_with_entity_marker": [240, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p10", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial [E1]GFP[/E1]-[E2]Cdc42p[/E2] staining.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GFP", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdc42p", "entity_2_idx": [[227, 233]], "entity_2_idx_in_text_with_entity_marker": [240, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p11", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the [E1]actin-binding proteins[/E1] tropomyosin and profilin also did not exhibit medial GFP-[E2]Cdc42p[/E2] staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[147, 169]], "entity_1_idx_in_text_with_entity_marker": [151, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Cdc42p", "entity_2_idx": [[227, 233]], "entity_2_idx_in_text_with_entity_marker": [240, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p12", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the [E1]actin[/E1]-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial [E2]GFP[/E2]-Cdc42p staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "GFP", "entity_2_idx": [[223, 226]], "entity_2_idx_in_text_with_entity_marker": [236, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p13", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the [E1]actin[/E1]-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the [E2]actin-binding proteins[/E2] tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding proteins", "entity_2_idx": [[147, 169]], "entity_2_idx_in_text_with_entity_marker": [160, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d782.s0_BioInfer.d782.s0.p14", "text": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.", "text_with_entity_marker": "Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the [E1]actin-binding proteins[/E1] tropomyosin and profilin also did not exhibit medial [E2]GFP[/E2]-Cdc42p staining.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[147, 169]], "entity_1_idx_in_text_with_entity_marker": [151, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "GFP", "entity_2_idx": [[223, 226]], "entity_2_idx_in_text_with_entity_marker": [236, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d197.s0_BioInfer.d197.s0.p0", "text": "Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families.", "text_with_entity_marker": "Exclusion of [E1]cardiac myosin heavy chain[/E1] and [E2]actin[/E2] gene involvement in hypertrophic cardiomyopathy of several French families.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[13, 39]], "entity_1_idx_in_text_with_entity_marker": [17, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d103.s0_BioInfer.d103.s0.p0", "text": "Bistratene A causes phosphorylation of talin and redistribution of actin microfilaments in fibroblasts: possible role for PKC-delta.", "text_with_entity_marker": "Bistratene A causes phosphorylation of [E1]talin[/E1] and redistribution of [E2]actin[/E2] microfilaments in fibroblasts: possible role for PKC-delta.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d103.s0_BioInfer.d103.s0.p1", "text": "Bistratene A causes phosphorylation of talin and redistribution of actin microfilaments in fibroblasts: possible role for PKC-delta.", "text_with_entity_marker": "Bistratene A causes phosphorylation of talin and redistribution of [E1]actin[/E1] microfilaments in fibroblasts: possible role for [E2]PKC-delta[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PKC-delta", "entity_2_idx": [[122, 131]], "entity_2_idx_in_text_with_entity_marker": [135, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d103.s0_BioInfer.d103.s0.p2", "text": "Bistratene A causes phosphorylation of talin and redistribution of actin microfilaments in fibroblasts: possible role for PKC-delta.", "text_with_entity_marker": "Bistratene A causes phosphorylation of [E1]talin[/E1] and redistribution of actin microfilaments in fibroblasts: possible role for [E2]PKC-delta[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PKC-delta", "entity_2_idx": [[122, 131]], "entity_2_idx_in_text_with_entity_marker": [135, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d205.s0_BioInfer.d205.s0.p0", "text": "Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.", "text_with_entity_marker": "Expression of [E1]E-cadherin[/E1], alpha-catenin and [E2]beta-catenin[/E2] in normal ovarian surface epithelium and epithelial ovarian cancers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[14, 24]], "entity_1_idx_in_text_with_entity_marker": [18, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[44, 56]], "entity_2_idx_in_text_with_entity_marker": [57, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d205.s0_BioInfer.d205.s0.p1", "text": "Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.", "text_with_entity_marker": "Expression of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2] and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[14, 24]], "entity_1_idx_in_text_with_entity_marker": [18, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[26, 39]], "entity_2_idx_in_text_with_entity_marker": [39, 52], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d205.s0_BioInfer.d205.s0.p2", "text": "Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.", "text_with_entity_marker": "Expression of E-cadherin, [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2] in normal ovarian surface epithelium and epithelial ovarian cancers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[26, 39]], "entity_1_idx_in_text_with_entity_marker": [30, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[44, 56]], "entity_2_idx_in_text_with_entity_marker": [57, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p0", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like TESK1, [E1]TESK2[/E1] phosphorylated cofilin specifically at Ser-3 and induced formation of [E2]actin[/E2] stress fibers and focal adhesions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TESK2", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[88, 93]], "entity_2_idx_in_text_with_entity_marker": [101, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p1", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like TESK1, TESK2 phosphorylated [E1]cofilin[/E1] specifically at Ser-3 and induced formation of [E2]actin[/E2] stress fibers and focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[88, 93]], "entity_2_idx_in_text_with_entity_marker": [101, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p2", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like [E1]TESK1[/E1], TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of [E2]actin[/E2] stress fibers and focal adhesions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TESK1", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[88, 93]], "entity_2_idx_in_text_with_entity_marker": [101, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p3", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like TESK1, [E1]TESK2[/E1] phosphorylated [E2]cofilin[/E2] specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TESK2", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[33, 40]], "entity_2_idx_in_text_with_entity_marker": [46, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p4", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like [E1]TESK1[/E1], [E2]TESK2[/E2] phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TESK1", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TESK2", "entity_2_idx": [[12, 17]], "entity_2_idx_in_text_with_entity_marker": [25, 30], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p5", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like [E1]TESK1[/E1], TESK2 phosphorylated [E2]cofilin[/E2] specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TESK1", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[33, 40]], "entity_2_idx_in_text_with_entity_marker": [46, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p0", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the [E1]fimbrin/plastin[/E1] family of [E2]actin[/E2] filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin/plastin", "entity_1_idx": [[151, 166]], "entity_1_idx_in_text_with_entity_marker": [155, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p1", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana [E1]fimbrin 1[/E1] (AtFim1) is a member of the [E2]fimbrin/plastin[/E2] family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin 1", "entity_1_idx": [[113, 122]], "entity_1_idx_in_text_with_entity_marker": [117, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin/plastin", "entity_2_idx": [[151, 166]], "entity_2_idx_in_text_with_entity_marker": [164, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p2", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 ([E1]AtFim1[/E1]) is a member of the [E2]fimbrin/plastin[/E2] family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AtFim1", "entity_1_idx": [[124, 130]], "entity_1_idx_in_text_with_entity_marker": [128, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin/plastin", "entity_2_idx": [[151, 166]], "entity_2_idx_in_text_with_entity_marker": [164, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p3", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana [E1]fimbrin 1[/E1] (AtFim1) is a member of the fimbrin/plastin family of [E2]actin[/E2] filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin 1", "entity_1_idx": [[113, 122]], "entity_1_idx_in_text_with_entity_marker": [117, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p4", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 ([E1]AtFim1[/E1]) is a member of the fimbrin/plastin family of [E2]actin[/E2] filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AtFim1", "entity_1_idx": [[124, 130]], "entity_1_idx_in_text_with_entity_marker": [128, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p5", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana [E1]fimbrin 1[/E1] ([E2]AtFim1[/E2]) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin 1", "entity_1_idx": [[113, 122]], "entity_1_idx_in_text_with_entity_marker": [117, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AtFim1", "entity_2_idx": [[124, 130]], "entity_2_idx_in_text_with_entity_marker": [137, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s0_BioInfer.d736.s0.p0", "text": "This approach is based on the assumption that an actin mutation that specifically impairs the interaction with an actin-binding protein will cause a phenotype similar to a null mutation in the gene that encodes the actin-binding protein.", "text_with_entity_marker": "This approach is based on the assumption that an [E1]actin[/E1] mutation that specifically impairs the interaction with an actin-binding protein will cause a phenotype similar to a null mutation in the gene that encodes the [E2]actin-binding protein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[215, 236]], "entity_2_idx_in_text_with_entity_marker": [228, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s0_BioInfer.d736.s0.p1", "text": "This approach is based on the assumption that an actin mutation that specifically impairs the interaction with an actin-binding protein will cause a phenotype similar to a null mutation in the gene that encodes the actin-binding protein.", "text_with_entity_marker": "This approach is based on the assumption that an actin mutation that specifically impairs the interaction with an [E1]actin-binding protein[/E1] will cause a phenotype similar to a null mutation in the gene that encodes the [E2]actin-binding protein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[114, 135]], "entity_1_idx_in_text_with_entity_marker": [118, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[215, 236]], "entity_2_idx_in_text_with_entity_marker": [228, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s0_BioInfer.d736.s0.p2", "text": "This approach is based on the assumption that an actin mutation that specifically impairs the interaction with an actin-binding protein will cause a phenotype similar to a null mutation in the gene that encodes the actin-binding protein.", "text_with_entity_marker": "This approach is based on the assumption that an [E1]actin[/E1] mutation that specifically impairs the interaction with an [E2]actin-binding protein[/E2] will cause a phenotype similar to a null mutation in the gene that encodes the actin-binding protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[114, 135]], "entity_2_idx_in_text_with_entity_marker": [127, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s1_BioInfer.d736.s1.p0", "text": "21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.", "text_with_entity_marker": "21 [E1]actin[/E1] mutations were analyzed in budding yeast, and specific regions of [E2]actin[/E2] subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[3, 8]], "entity_1_idx_in_text_with_entity_marker": [7, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[75, 80]], "entity_2_idx_in_text_with_entity_marker": [88, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s1_BioInfer.d736.s1.p1", "text": "21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.", "text_with_entity_marker": "21 actin mutations were analyzed in budding yeast, and specific regions of [E1]actin[/E1] subdomain 1 were implicated in the interaction with fimbrin, an [E2]actin[/E2] filament-bundling protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s1_BioInfer.d736.s1.p2", "text": "21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.", "text_with_entity_marker": "21 actin mutations were analyzed in budding yeast, and specific regions of [E1]actin[/E1] subdomain 1 were implicated in the interaction with [E2]fimbrin[/E2], an actin filament-bundling protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s1_BioInfer.d736.s1.p3", "text": "21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.", "text_with_entity_marker": "21 [E1]actin[/E1] mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an [E2]actin[/E2] filament-bundling protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[3, 8]], "entity_1_idx_in_text_with_entity_marker": [7, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s1_BioInfer.d736.s1.p4", "text": "21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.", "text_with_entity_marker": "21 [E1]actin[/E1] mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with [E2]fimbrin[/E2], an actin filament-bundling protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[3, 8]], "entity_1_idx_in_text_with_entity_marker": [7, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d736.s1_BioInfer.d736.s1.p5", "text": "21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.", "text_with_entity_marker": "21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with [E1]fimbrin[/E1], an [E2]actin[/E2] filament-bundling protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[133, 140]], "entity_1_idx_in_text_with_entity_marker": [137, 144], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
